<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunity - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pathology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">61</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 13667,
    "choices": [
      {
        "id": 54629,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of PD1 receptor on T-cells </span></span></span></span></p>"
      },
      {
        "id": 54630,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upregulation of expression of PDL1 </span></span></span></span></p>"
      },
      {
        "id": 54631,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of galectin</span></span></span></span></p>"
      },
      {
        "id": 54632,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of regulatory T-cells</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following mechanisms does not lead to immune evasion by the tumor cells?</span></span></p>",
    "unique_key": "Q1562625",
    "question_audio": null,
    "question_video": null,
    "map_id": 31852,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Inhibition of PD1 receptor on T-cells</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of<strong> PD-1 receptor (Programmed death -1 receptor) </strong>on T cells causes activation of<strong> immunity against the tumor cells</strong>, not evasion.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PD-1 receptors present on T cells inhibit T-cell activation. </strong>This allows tumors to <strong>evade the host immunity </strong>by the <strong>upregulation </strong>of the expression of factors like <strong>PD-L1 and PD-L2, which act on PD-1 receptors.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibiting the PD1 receptor on T cells </strong>actually leads to the <strong>activation of the immune response against tumor cells.</strong> This is the basis for some of the <strong>cancer immunotherapies,</strong> which <strong>block PD1 </strong>to prevent the<strong> tumor cells </strong>from <strong>evading the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Upregulation of expression of PDL1:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor cells often upregulate PD-L1, </strong>which binds to the <strong>PD1 receptor on T cells,</strong> leading to the<strong> inhibition of the immune response</strong> against the<strong> tumor,</strong> effectively allowing the <strong>tumor to evade the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Induction of galectin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor cells can induce <strong>galectins,</strong> which are<strong> beta-galactoside-binding proteins</strong> that can <strong>negatively regulate T-cell apoptosis</strong>, affect<strong> T-cell receptor signaling, </strong>or contribute to the creation of an<strong> immunosuppressive tumor microenvironment, facilitating immune evasion</strong>.</span></span></span></span></p>\r\n\r\n<p>;<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Induction of regulatory T-cells:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumors </strong>may induce <strong>regulatory T cells (Tregs), </strong>which suppress the activation of the immune system and maintain<strong> tolerance to self-antigens, </strong>thus aiding in <strong>tumor immune evasion.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibition of the PD1 receptor on T cells does not </strong>lead to <strong>immune evasion</strong> by tumor cells; rather, it <strong>activates the immune response</strong> against the <strong>tumor. PD1 receptor</strong> inhibition is a strategy used in <strong>cancer immunotherapy</strong> to overcome <strong>tumor-induced immune</strong> <strong>suppression.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 312</span></span></strong></span></span></p>",
    "correct_choice_id": 54629,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14140,
    "choices": [
      {
        "id": 56521,
        "text": "<p><span style=\"font-size:12pt;\">NOD like receptor</span></p>"
      },
      {
        "id": 56522,
        "text": "<p><span style=\"font-size:12pt;\">GPCR</span></p>"
      },
      {
        "id": 56523,
        "text": "<p><span style=\"font-size:12pt;\">C type of lectin receptor</span></p>"
      },
      {
        "id": 56524,
        "text": "<p><span style=\"font-size:12pt;\">Toll like receptor</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old male with a history of hypertension presents with a sudden onset of severe pain, redness, and swelling in the big toe. His serum uric acid levels are elevated. Which pattern recognition receptor is most likely involved in the inflammatory response seen in this patient's condition?</span></p>",
    "unique_key": "Q2556036",
    "question_audio": null,
    "question_video": null,
    "map_id": 31837,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) NOD like receptor</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">NOD like receptor is useful for detection of danger associated molecular patterns like <strong>uric acid, cholesterol, K+ efflux and depletion of ATP</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>NOD-like Receptor (NLR)</strong> NOD-like receptors are <strong>intracellular sensors of the innate immune system </strong>that detect <strong>danger-associated molecular patterns (DAMPs) </strong>and<strong> pathogen-associated molecular patterns (PAMPs). </strong>They are implicated in the inflammatory response to <strong>uric acid crystals in gout</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: G Protein-Coupled Receptor (GPCR):</strong> GPCRs are a<strong> large protein family </strong>of receptors that sense molecules<strong> outside the cell and activate internal signal transduction pathways </strong>and, ultimately, cellular responses. They are not primarily known for recognizing uric acid crystals.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: C-type Lectin Receptor (CLR):</strong> C-type lectin receptors are a <strong>class of pattern recognition receptors </strong>that are key players in the immune system,<strong> recognizing fungal pathogens </strong>and playing a role in<strong> antifungal immunity. </strong>They are not directly involved in the recognition of uric acid crystals.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Toll-like Receptor (TLR):</strong> Toll-like receptors are a <strong>class of proteins </strong>that play a key role in the <strong>innate immune system</strong>. They recognize structurally conserved molecules derived from <strong>microbes and are important in the initial immune response, </strong>not specifically in the recognition of uric acid crystals associated with gout.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>NOD-like receptors (NLRs) </strong>are involved in the detection of<strong> danger-associated molecular patterns </strong>such as<strong> uric acid, </strong>which is relevant in the pathogenesis of gout.</span></p>",
    "correct_choice_id": 56521,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14141,
    "choices": [
      {
        "id": 56525,
        "text": "<p><span style=\"font-size:12pt;\">1:1</span></p>"
      },
      {
        "id": 56526,
        "text": "<p><span style=\"font-size:12pt;\">1:3</span></p>"
      },
      {
        "id": 56527,
        "text": "<p>3:1</p>"
      },
      {
        "id": 56528,
        "text": "<p><span style=\"font-size:12pt;\">1:4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 30-year-old man participates in a clinical study examining immune function. He is in excellent health with no history of immune-related disorders. A complete blood count with differential and a lymphocyte subset panel are performed. Which of the following is the expected normal ratio of T cells to B cells in this individual's peripheral blood?</span></p>",
    "unique_key": "Q8364436",
    "question_audio": null,
    "question_video": null,
    "map_id": 31838,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 3:1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the peripheral blood of a healthy individual,<strong> T cells are 60\u201370% and B cells are 10\u201320% of the lymphocytes. </strong>So, the best answer with the given options is <strong>3:1.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1:1</strong>: Would suggest an abnormally high B cell count or low T cell count</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 1:3 and D. 1:4:</strong> Suggest a B cell-predominant profile, which is not normal for healthy adults</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The typical ratio of<strong> T cells to B cells in the peripheral blood </strong>of a healthy individual is approximately <strong>3:1</strong>, reflecting the <strong>predominance of T cells, which comprise 60\u201370% of lymphocytes, while B cells make up about 10\u201320%.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical Relevance:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A 3:1 T:B cell ratio is considered physiological.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Altered ratios can be seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Immunodeficiencies</span></li><li><span style=\"font-size:12.0pt;\">Leukemias/lymphomas</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune diseases</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p195 )</strong></span></p>",
    "correct_choice_id": 56527,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14142,
    "choices": [
      {
        "id": 56529,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD25 </span></span></span></p>"
      },
      {
        "id": 56530,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD3 </span></span></span></p>"
      },
      {
        "id": 56531,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD94 </span></span></span></p>"
      },
      {
        "id": 56532,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD68 </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old female with a history of recurrent viral infections is referred to an immunologist for evaluation. Laboratory studies are ordered to assess her immune cell populations, including a flow cytometry panel to identify various lymphocyte subsets based on surface markers. Which of the following cell surface markers is most commonly associated with natural killer (NK) cells?</span></span></span></p>",
    "unique_key": "Q7941276",
    "question_audio": null,
    "question_video": null,
    "map_id": 31839,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) CD94 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD94:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD94 is part of a family of<strong> C-type lectin receptors </strong>that are predominantly expressed on <strong>NK cells and a subset of CD8+ T cells. </strong>It forms a complex with <strong>NKG2A/B/C </strong>to interact with<strong> non-classical MHC class I molecules like HLA-E.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CD25:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD25 is the<strong> alpha chain </strong>of the <strong>IL-2 receptor</strong>, which is expressed on activated <strong>T and B cells, and some NK cells. </strong>It&#39;s <strong>not specific for NK cells</strong>, as it is also present on regulatory <strong>T cells (Tregs).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: CD3:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD3 is a complex of proteins associated with the <strong>T-cell receptor (TCR) on T-lymphocytes. </strong>It is<strong> not found on NK cells, </strong>which do not express TCRs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: CD68:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD68 is a marker associated with <strong>macrophages </strong>and is <strong>not expressed on NK cells</strong>. It is typically used to identify cells of the <strong>myeloid lineage</strong>, particularly in the context of<strong> tissue-resident macrophages.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>surface marker CD94 </strong>is predominantly expressed on <strong>natural killer (NK) cells and a subset of CD8+ T cells </strong>and is involved in the recognition of<strong> non-classical MHC class I molecules</strong></span></span></span></p>",
    "correct_choice_id": 56531,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14143,
    "choices": [
      {
        "id": 56533,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha defensins</span></span></span></p>"
      },
      {
        "id": 56534,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B lymphocytes</span></span></span></p>"
      },
      {
        "id": 56535,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delta gamma T lymphocytes</span></span></span></p>"
      },
      {
        "id": 56536,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lectin pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with a suspected immune deficiency, various components of the immune system are being assessed to identify the potential defect. Which of the following immune components is primarily associated with adaptive immunity rather than innate immunity?</span></span></span></p>",
    "unique_key": "Q5524943",
    "question_audio": null,
    "question_video": null,
    "map_id": 31840,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) B lymphocytes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B Lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B lymphocytes, or B cells, are central to<strong> adaptive immunity</strong>. They are responsible for the production of antibodies in response to <strong>specific antigens</strong>, a process that involves<strong> clonal selection and memory cell formation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Alpha Defensins:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Alpha defensins are<strong> antimicrobial peptides </strong>produced by<strong> Paneth cells in the intestines</strong>. They play a crucial role in the <strong>innate immune </strong>response by directly killing <strong>microbes and contribute to the innate defense of mucosal surfaces.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Delta Gamma T Lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Delta gamma T cells (&gamma;&delta; T cells) are a<strong> subset of T cells </strong>that have T cell receptors different from the classic <strong>&alpha;&beta; T cell receptors. </strong>These cells can respond to certain antigens <strong>without </strong>the need for <strong>antigen processing and presentation by MHC molecules</strong>, bridging<strong> innate and adaptive immunity</strong>. They are often considered a part of the innate immune system due to their<strong> rapid response and lack of requirement for specific antigen presentation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lectin Pathway:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The lectin pathway is part of the <strong>complement system</strong>, which is a key component of the innate immune system. It involves the binding of<strong> mannose-binding lectin to pathogens</strong>, leading to their <strong>opsonization and subsequent phagocytosis or lysis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B lymphocytes </strong>are part of the<strong> adaptive immune system </strong>and are responsible for<strong> humoral immunity </strong>through the <strong>production of antibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p195)</span></strong></span></span></p>",
    "correct_choice_id": 56534,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14144,
    "choices": [
      {
        "id": 56537,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Helper T cells</span></span></span></p>"
      },
      {
        "id": 56538,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Natural killer cells</span></span></span></p>"
      },
      {
        "id": 56539,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suppressor T cells</span></span></span></p>"
      },
      {
        "id": 56540,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic T cells</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC-I will present antigen to:</span></span></span></p>",
    "unique_key": "Q4171634",
    "question_audio": null,
    "question_video": null,
    "map_id": 31841,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Cytotoxic T cells </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&bull; <strong>MHC I</strong> presents antigen to <strong>CD8 T cell</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&bull;<strong> MHC II </strong>presents antigen to <strong>CD4 T cell</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cytotoxic T cells <strong>(CD8+ T cells) </strong>are directly activated by <strong>antigens presented on MHC class I molecules. </strong>These cells are important for the elimination of<strong> virus-infected cells and tumor cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Helper T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Helper T cells <strong>(CD4+ T cells) </strong>are primarily activated by <strong>antigens presented on MHC class II molecules</strong>. They are crucial for the <strong>orchestration of the immune response,</strong> including the activation of<strong> B cells and other T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Natural killer cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Natural killer (NK) cells are part of the<strong> innate immune system</strong> and <strong>do not require antigen presentation</strong> by <strong>MHC molecules for activation</strong>. Instead, they <strong>monitor </strong>the level of<strong> MHC class I expression </strong>and can be<strong> activated </strong>when they detect <strong>reduced MHC I levels</strong>, which is often indicative of<strong> viral infection or malignancy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Suppressor T cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Suppression or regulatory T cells (Tregs), often referred to in the context of <strong>CD4+ T cells </strong>with suppressive function,<strong> do not directly interact with MHC class I. </strong>They regulate the immune response to maintain tolerance to <strong>self-antigens and prevent autoimmune disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I molecules present antigens to cytotoxic T cells (CD8+ T cells) whereas MHC class II molecules present antigens to CD4+ T cells. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p198)</span></strong></span></span></p>",
    "correct_choice_id": 56540,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14146,
    "choices": [
      {
        "id": 56545,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigen Specific Receptors </span></span></span></p>"
      },
      {
        "id": 56546,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class I MHC Expression </span></span></span></p>"
      },
      {
        "id": 56547,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive selection during development </span></span></span></p>"
      },
      {
        "id": 56548,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the process of lymphocyte development, which of the following processes occurs in T cells but not in B cells?</span></span></span></p>",
    "unique_key": "Q6833227",
    "question_audio": null,
    "question_video": null,
    "map_id": 31842,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Positive selection during development</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive Selection during Development:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Positive selection ensures that developing<strong> T cells in the thymus cortex </strong>have <strong>TCRs </strong>that can appropriately recognize<strong> self-MHC molecules</strong>. This process<strong> does not occur in B cells; </strong>their selection processes, including &quot;receptor editing&quot; for self-reactivity, occur in the bone marrow and peripheral lymphoid organs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Antigen-Specific Receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Both<strong> B cells and T cells </strong>develop <strong>antigen-specific receptors. </strong>B cells produce a <strong>membrane-bound form of antibody </strong>as their <strong>antigen-specific receptor</strong>, while <strong>T cells develop T-cell receptors (TCRs).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Class I MHC Expression:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Both<strong> B cells and T cells express Class I MHC molecules. </strong>These are present on nearly all <strong>nucleated cells in the body </strong>and are important for presenting <strong>endogenous antigens to CD8+ cytotoxic T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: All of the Above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Since only positive selection is unique to T cells, this option is<strong> not correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive selection during development, which ensures that<strong> T cells have T-cell receptors capable of recognizing self-MHC molecules,</strong> occurs in <strong>T cells</strong> but <strong>not in B cells.</strong> Understanding the <strong>unique and shared aspects of T and B cell development</strong> is important for recognizing how <strong>different immune deficiencies </strong>can affect the <strong>immune system&#39;s function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Immunology by SK Gupta 1st/142-150, Robbins 10<sup>th</sup> 194-6, 216)</span></span></strong></p>",
    "correct_choice_id": 56547,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14147,
    "choices": [
      {
        "id": 56549,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alfa and Beta chain </span></span></span></p>"
      },
      {
        "id": 56550,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distal domain alfa 1 and 2 </span></span></span></p>"
      },
      {
        "id": 56551,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alfa and beta microglobulin </span></span></span></p>"
      },
      {
        "id": 56552,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proximal domain alfa 1 and 2 </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the structure of MHC molecules and their role in antigen presentation. When considering MHC class I molecules and their interaction with T cells, which structural component of the MHC class I molecule is responsible for forming the peptide-binding cleft?</span></span></span></p>",
    "unique_key": "Q9215139",
    "question_audio": null,
    "question_video": null,
    "map_id": 31843,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Distal domain alfa 1 and 2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distal domain alpha 1 and 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>peptide-binding cleft of MHC class I molecules </strong>is formed by the<strong> distal domains of the alpha 1 and alpha 2 chains. </strong>This is where <strong>peptides bind for presentation to CD8+ cytotoxic T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Alpha and Beta chain:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>MHC class II molecule </strong>consists of two separate protein chains,<strong> alpha and beta</strong>, each contributing to the formation of the<strong> antigen-binding cleft</strong>. This option is <strong>not accurate for MHC class I molecules</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Alpha and Beta2-microglobulin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta 2-microglobulin is a component of the<strong> MHC class I molecule </strong>but <strong>does not form part of the antigen-binding cleft</strong>. Instead, it supports the structure of the<strong> MHC class I molecule.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Proximal domain alpha 1 and 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The proximal domains of MHC molecules are<strong> not involved in peptide binding</strong>; they are closer to the membrane and play a role in maintaining the <strong>structure of the molecule on the cell surface.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> peptide-binding cleft of MHC class I molecules </strong>is formed by the <strong>distal domains of the alpha 1 and alpha 2 chains </strong>whereas <strong>peptide-binding cleft of MHC class II molecules </strong>is formed by the <strong>distal domains of the alpha 1 and beta 1 chains</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 195)</span></span></strong></p>",
    "correct_choice_id": 56550,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14148,
    "choices": [
      {
        "id": 56553,
        "text": "<p><span style=\"font-size:12pt;\">Memory</span></p>"
      },
      {
        "id": 56554,
        "text": "<p><span style=\"font-size:12pt;\">Immunoglobulin production</span></p>"
      },
      {
        "id": 56555,
        "text": "<p><span style=\"font-size:12pt;\">Activation of macrophages</span></p>"
      },
      {
        "id": 56556,
        "text": "<p><span style=\"font-size:12pt;\">Cytotoxicity</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following require normal functioning of CD4 molecule except:</span></p>",
    "unique_key": "Q9982863",
    "question_audio": null,
    "question_video": null,
    "map_id": 31844,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Cytotoxicity</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">CD4+ T cells are generally not cytotoxic; this function is characteristic of CD8+ cytotoxic T cells which kill virus-infected cells and tumor cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Memory: CD4+ T cells </strong>differentiate into <strong>memory T cells </strong>following <strong>antigen exposure</strong>, which provides <strong>long-term immunity by remembering the antigen for faster response upon re-exposure</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Immunoglobulin Production:</strong> CD4+ T cells, particularly the Th2 subset, are critical for B cell help, leading to B cell proliferation, differentiation, and subsequent immunoglobulin production.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Activation of Macrophages:</strong> <strong>Th1 subset of CD4+ T cells </strong>can activate <strong>macrophages </strong>by secreting cytokines such as<strong> IFN-\u03b3 and TNF-\u03b1</strong>, enhancing their <strong>microbicidal activity</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CD4+ T cells </strong>are pivotal for <strong>immune responses</strong>, including <strong>memory formation and macrophage activation,</strong> and are responsible for formation of different classes of antibodies (isotype switching in antibodies)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 190-191)</strong></span></p>",
    "correct_choice_id": 56556,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14149,
    "choices": [
      {
        "id": 56557,
        "text": "<p><span style=\"font-size:12pt;\">Binds to B7 and CD28 co-stimulatory molecules</span></p>"
      },
      {
        "id": 56558,
        "text": "<p><span style=\"font-size:12pt;\">Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation</span></p>"
      },
      {
        "id": 56559,
        "text": "<p><span style=\"font-size:12pt;\">Binds to the CD4 + molecule causing T cell activation</span></p>"
      },
      {
        "id": 56560,
        "text": "<p><span style=\"font-size:12pt;\">Is presented by macrophages to a larger-than-normal number of T helper CD4 + lymphocytes</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">During a hospital outbreak of a severe systemic inflammatory response syndrome, an infectious disease consultant suggests the possibility of superantigen involvement. Which of the following mechanisms best l the action of bacterial superantigens in the context of this condition?</span></p>",
    "unique_key": "Q3255044",
    "question_audio": null,
    "question_video": null,
    "map_id": 31845,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Binds to the beta chain of TCR and MHC class II molecules of APC stimulating T cell activation:</strong> Superantigens bridge the <strong>TCR on T cells and MHC class II on antigen-presenting cells outside the conventional peptide-binding groove</strong>, leading to widespread <strong>T cell activation </strong>without the need for <strong>specific antigen recognition.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Binds to B7 and CD28 co-stimulatory molecules:</strong> These molecules are involved in the <strong>second signal required for T cell activation. </strong>However, superantigens do not typically bind to these molecules directly.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Binds to the CD4+ molecule causing T cell activation:</strong> While CD4+ is a <strong>co-receptor for TCRs on helper T cells, superantigens </strong>do<strong> not</strong> primarily function by <strong>binding to CD4+ molecules. </strong>They act more broadly to <strong>cross-link TCRs and MHC class II molecules.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Is presented by macrophages to a larger-than-normal number of T helper CD4+ lymphocytes:</strong> Superantigens do not get presented in the conventional sense as <strong>peptides by APCs</strong>. Instead, they interact with<strong> TCRs and MHC class II molecules to non-specifically </strong>activate a large number of<strong> T cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Superantigens </strong>are bacterial products that can cause a <strong>massive T cell response </strong>by binding to the beta chain of<strong> TCRs and MHC class II molecules on APCs</strong>, leading to the <strong>non-specific activation of T cells. </strong>Some examples include <strong>toxic shock syndrome toxin-1 (TSST-1 produced in a female using unhygienic sanitory tampons), Streptococcal pyrogenic exotoxins (SPE), Staphylococcal enterotoxins (SE), and enterotoxogenic E. coli (ETEC) enterotoxin.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture2.jpg\" alt=\"\" width=\"700\" height=\"529\"></span></p>",
    "correct_choice_id": 56558,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14150,
    "choices": [
      {
        "id": 56561,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RA </span></span></span></p>"
      },
      {
        "id": 56562,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RB </span></span></span></p>"
      },
      {
        "id": 56563,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RC </span></span></span></p>"
      },
      {
        "id": 56564,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RO</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In evaluating a patient&#39;s immune status, particularly the cellular immunity involving T lymphocytes, which surface marker is characteristic of memory T cells as opposed to naive T cells?</span></span></span></p>",
    "unique_key": "Q7123845",
    "question_audio": null,
    "question_video": null,
    "map_id": 31846,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) CD45RO </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD45RO:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RO is the marker associated with <strong>memory T cells</strong>. These cells have previously <strong>encountered antigen </strong>and can quickly expand upon<strong> re-exposure to that specific antigen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CD45RA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RA is a marker typically found on <strong>naive T cells</strong>. These cells have <strong>not yet </strong>encountered their <strong>specific antigen </strong>and are<strong> not yet differentiated into effector or memory cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: CD45RB:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RB is expressed on <strong>all leukocytes </strong>and is <strong>not specific to either naive or memory T cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: CD45RC:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD45RC&#39;s expression can vary but is not specifically associated with<strong> memory T cells</strong>. It is another<strong> isoform of the CD45 molecule</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CD45RO </strong>is a cell surface marker characteristic of <strong>memory T cells</strong>, which play a crucial role in the <strong>immune system&#39;s ability </strong>to respond more<strong> rapidly and effectively </strong>upon <strong>re-exposure to pathogens.</strong></span></span></p>",
    "correct_choice_id": 56564,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 14158,
    "choices": [
      {
        "id": 56593,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC III </span></span></span></p>"
      },
      {
        "id": 56594,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I </span></span></span></p>"
      },
      {
        "id": 56595,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class II </span></span></span></p>"
      },
      {
        "id": 56596,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male presents with fever, fatigue, and abdominal pain. Laboratory tests reveal elevated liver enzymes and positive serology for hepatitis B virus. Which of the following molecules is involved in presenting viral peptides to cytotoxic T cells? </span></span></span></p>",
    "unique_key": "Q9813654",
    "question_audio": null,
    "question_video": null,
    "map_id": 31847,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) MHC class I </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC class I molecules</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are responsible for presenting<strong> endogenous peptides</strong>, including <strong><em>viral peptides, to cytotoxic T cells</em></strong>. In this case, the patient&#39;s immune system is likely <strong>mounting a cytotoxic T cell response </strong>against the<strong> hepatitis B virus</strong>, which is causing <strong>liver inflammation and elevated liver enzymes</strong>.<strong> CD4 and CD8 </strong>are <strong>co-receptors </strong>expressed on T cells that interact with<strong> MHC molecules</strong>, but they are <strong>not </strong>directly involved in <strong>peptide presentation. MHC class II molecules </strong>are involved in <strong>presenting exogenous peptides to helper T cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MHC Class I:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MHC class I molecules present <strong>endogenous peptides</strong>, including <strong>viral antigens, to cytotoxic T cells</strong>. All <strong>nucleated cells express MHC class I</strong>, which is critical for<strong> immune surveillance and the detection of intracellular pathogens like viruses</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: MHC Class III:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is<strong> no MHC class III involved in antigen presentation to T cells</strong>. MHC class III genes encode components of the <strong>complement system and some inflammatory cytokines</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: MHC Class II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MHC class II molecules present <strong>exogenous antigens to helper T cells (CD4+ T cells). </strong>These are typically expressed by <strong>professional antigen-presenting cells </strong>such as <strong>dendritic cells, macrophages, and B cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MHC class I</strong>, which presents <strong>endogenous viral peptides to cytotoxic T cells</strong>, initiates a <strong>cellular immune response </strong>essential for the control of<strong> viral infections such as hepatitis B</strong>. </span></span></span></p>",
    "correct_choice_id": 56594,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14167,
    "choices": [
      {
        "id": 56629,
        "text": "<p><span style=\"font-size:12pt;\">Infections</span></p>"
      },
      {
        "id": 56630,
        "text": "<p><span style=\"font-size:12pt;\">Expression of cryptic antigens</span></p>"
      },
      {
        "id": 56631,
        "text": "<p><span style=\"font-size:12pt;\">Negative selective of autoreactive T cells in thymus</span></p>"
      },
      {
        "id": 56632,
        "text": "<p><span style=\"font-size:12pt;\">Receptor editing of T cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In a patient presenting with signs and symptoms suggestive of an autoimmune disorder, which of the following mechanisms is most likely to contribute to the prevention, rather than the development, of autoimmunity?</span></p>",
    "unique_key": "Q3783514",
    "question_audio": null,
    "question_video": null,
    "map_id": 31849,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Negative selective of autoreactive T cells in thymus</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Negative selection of autoreactive T cells is a defense mechanism to <strong>reduce the chances of autoimmune disorders</strong>. It is achieved through the process of<strong> apoptosis</strong>.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Negative Selection of T cells in the Thymus:</strong> Negative selection in the<strong> thymus </strong>eliminates T cells that have <strong>high affinity for self-antigens</strong>, thus serving as a central tolerance mechanism to <strong>reduce the risk of autoimmunity.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Infections:</strong> Infections can sometimes<strong> trigger autoimmunity </strong>through mechanisms such as<strong> molecular mimicry</strong>, where an <strong>immune response to an infectious agent cross-reacts with self-antigens.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Expression of Cryptic Antigens:</strong> Cryptic antigens are <strong>self-antigens </strong>that are normally <strong>not visible to the immune system </strong>but can cause an<strong> autoimmune response </strong>when exposed due to<strong> tissue damage or other processes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Receptor Editing of T cells:</strong> Receptor editing refers to the <strong>alteration of B cell receptors on immature B cells </strong>in the bone marrow. If an immature B cell has a<strong> receptor that binds to self-antigens</strong>, the cell can edit its receptor to avoid <strong>self-reactivity</strong>. However, failures in this process can contribute to autoimmunity.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phenomenon of receptor editing is not applicable to T cells</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Negative selection of &nbsp;autoreactive T cells in the thymus, </strong>which involves the <strong>apoptosis of T cells </strong>that react strongly to <strong>self-antigens</strong>, is a defence mechanism against<strong> autoimmunity, </strong>not a contributing factor to it. This central tolerance mechanism is crucial for preventing the development of autoimmune diseases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Reference Robbins 10<sup>th</sup>/218-220</strong></span></p>",
    "correct_choice_id": 56631,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14171,
    "choices": [
      {
        "id": 56645,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transplant rejection phenomenon </span></span></span></p>"
      },
      {
        "id": 56646,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Governing susceptibility to autoimmune diseases </span></span></span></p>"
      },
      {
        "id": 56647,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune surveillance </span></span></span></p>"
      },
      {
        "id": 56648,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigen presentation and elimination </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of human leukocyte antigen (HLA) genetics, the HLA class III region has been implicated in which of the following processes?</span></span></span></p>",
    "unique_key": "Q6843193",
    "question_audio": null,
    "question_video": null,
    "map_id": 31851,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Governing susceptibility to autoimmune diseases </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Governing Susceptibility to Autoimmune Diseases:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> HLA class III region </strong>contains genes for<strong> complement components</strong>, such as <strong>C2 and C4</strong>, which are involved in the <strong>classical complement pathway</strong>. Deficiencies in these components have been linked with an <strong>increased susceptibility to autoimmune diseases</strong>, such as <strong>systemic lupus erythematosus (SLE).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Transplant Rejection Phenomenon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Transplant rejection typically involves <strong>HLA class I and class II regions, </strong>as these regions encode for molecules directly involved in <strong>antigen presentation </strong>that can be recognized by the<strong> recipient&#39;s immune system</strong>, leading to <strong>rejection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Immune Surveillance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While immune surveillance is an essential function of the <strong>immune system </strong>in identifying and d<strong>estroying pathogens and abnormal cells</strong>, it is more closely associated with <strong>HLA class I and II molecules&#39; </strong>ability to present antigens.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Antigen Presentation and Elimination:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Antigen presentation and elimination are directly related to <strong>HLA class I and class II molecules</strong>, which present <strong>peptides to T cells</strong>. The <strong>HLA class III region is not primarily involved in antigen presentation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HLA class III region </strong>is involved in the regulation of <strong>susceptibility to autoimmune diseases </strong>due to its role in<strong> encoding early components of the complement system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: 10<sup>th</sup>/ 215) </span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></strong></span></span></p>",
    "correct_choice_id": 56646,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 14181,
    "choices": [
      {
        "id": 56685,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area postrema </span></span></span></p>"
      },
      {
        "id": 56686,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loop of Henle </span></span></span></p>"
      },
      {
        "id": 56687,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic nerve </span></span></span></p>"
      },
      {
        "id": 56688,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seminiferous tubules </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anatomical locations is considered an immune-privileged site, where immune responses are typically reduced to prevent potential damage from inflammation?</span></span></span></p>",
    "unique_key": "Q2342024",
    "question_audio": null,
    "question_video": null,
    "map_id": 31853,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Seminiferous tubules </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>testis, eye, and brain, </strong>all of which are called <strong>immune privileged sites </strong>because it is difficult to<strong> induce immune responses </strong>to <strong>antigens </strong>introduced into these sites. If the<strong> antigens of these tissues </strong>are released, for example, as a <strong>consequence of trauma or infection</strong>, the result may be an <strong>immune response </strong>that leads to <strong>prolonged tissue inflam&shy;mation and injury</strong>. This is the postulated mechanism for<strong> post-traumatic orchitis and uveitis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seminiferous tubules:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The seminiferous tubules, located within the<strong> testis, </strong>are indeed an <strong>immune-privileged </strong>site to protect <strong>spermatogenic cells </strong>from<strong> autoimmune responses</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Area postrema:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The area postrema is a structure in the brain that<strong> controls vomiting in response to toxins</strong>, but it is not traditionally considered an immune-privileged site.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Loop of Henle:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Loop of Henle is part of the <strong>nephron in the kidney </strong>involved in the <strong>concentration of urine </strong>and is <strong>not an immune-privileged site</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Optic nerve:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the optic nerve is part of the<strong> central nervous system (CNS), </strong>which is considered <strong>immune-privileged</strong>, the term typically refers to the <strong>eye as a whole </strong>rather than individual structures<strong> within it</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immune-privileged </strong>sites such as the<strong> seminiferous tubules, eyes, and brain </strong>are areas where<strong> immune responses are specifically downregulated </strong>to prevent damage that can occur from<strong> inflammation</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 214)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><em> </em></span></strong></span></span></p>",
    "correct_choice_id": 56688,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14203,
    "choices": [
      {
        "id": 56773,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b </span></span></p>"
      },
      {
        "id": 56774,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-d, 3-a, 4-c </span></span></span></p>"
      },
      {
        "id": 56775,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-d, 3-b, 4-a </span></span></span></p>"
      },
      {
        "id": 56776,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-a, 3-b, 4-c </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following complement deficiencies with the disorders given:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-104551.JPG\" style=\"height:225px; width:700px\" /></span></span></span></p>",
    "unique_key": "Q6799999",
    "question_audio": null,
    "question_video": null,
    "map_id": 31854,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1-b, 2-d, 3-a, 4-c </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/01/screenshot-2024-06-01-122206.JPG\" style=\"height:217px; width:700px\" /></p>",
    "correct_choice_id": 56774,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14211,
    "choices": [
      {
        "id": 56805,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mature dendritic cell </span></span></span></p>"
      },
      {
        "id": 56806,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular dendritic cell </span></span></span></p>"
      },
      {
        "id": 56807,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macrophages </span></span></span></p>"
      },
      {
        "id": 56808,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B cell </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following cells would you identify as the most potent stimulator of na&iuml;ve T cells?</span></span></span></p>",
    "unique_key": "Q1555387",
    "question_audio": null,
    "question_video": null,
    "map_id": 31831,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Mature dendritic cell </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mature dendritic cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mature dendritic cells are the most potent <strong>APCs due to their high expression of MHC class II molecules </strong>and costimulatory molecules necessary for <strong>na&iuml;ve T cell activation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Follicular dendritic cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Follicular dendritic cells, primarily found in the<strong> lymph nodes</strong>, do not express MHC class II molecules; they<strong> present antigens to B cells in humoral immune responses, </strong>not na&iuml;ve T cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Macrophages:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While macrophages can serve as<strong> APCs and activate T cells</strong>, they are <strong>less potent</strong> than <strong>dendritic cells </strong>and typically engage in <strong>phagocytosis and antigen presentation during inflammation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: B cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B cells can present antigens to <strong>helper T cells</strong>, particularly in the context of <strong>humoral immune responses, </strong>but they are not the <strong>most potent APCs </strong>for initiating responses in na&iuml;ve T cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most <strong>potent stimulator </strong>of a <strong>na&iuml;ve T cell </strong>is the <strong>mature dendritic cell </strong>due to its<strong> high expression of MHC molecules </strong>and the ability to provide the necessary <strong>costimulatory signals </strong>required for<strong> T cell activation. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 191) </span></em></strong></span></span></p>",
    "correct_choice_id": 56805,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 14213,
    "choices": [
      {
        "id": 56813,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perforin and granzyme mediated apoptosis </span></span></span></p>"
      },
      {
        "id": 56814,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADD ligand apoptosis </span></span></span></p>"
      },
      {
        "id": 56815,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcription of nuclear factor mediated by NF-&kappa;</span><em><span style=\"font-family:Symbol\">b</span></em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> which recruits cytokines </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></span></span></p>"
      },
      {
        "id": 56816,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclin </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toll like receptors, recognize bacterial products and stimulates immune response by: </span></span></span></p>",
    "unique_key": "Q7751785",
    "question_audio": null,
    "question_video": null,
    "map_id": 31832,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Transcription of nuclear factor mediated by NF-&kappa;&beta; which recruits cytokines</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transcription </strong>of nuclear factor mediated by <strong>NF-&kappa;&beta; </strong>which <strong>recruits cytokines </strong>is a pivotal response in th<strong>e innate immune system</strong>. NF-&kappa;&beta; is a<strong> transcription factor </strong>that is activated by <strong>Toll-like receptors </strong>upon recognition of<strong> pathogen-associated molecular patterns</strong>, leading to the production of <strong>pro-inflammatory cytokines</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Perforin and granzyme-mediated apoptosis</strong> is a mechanism utilized by <strong>cytotoxic T cells and natural killer cells</strong> to induce <strong>cell death in infected or abnormal cells. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FADD ligand apoptosis </strong>involves the<strong> Fas-associated death domain protein</strong>, part of the <strong>extrinsic pathway for apoptosis, </strong>typically triggered by the<strong> Fas ligand </strong>binding to its receptor. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Cyclin proteins</strong> are involved in the regulation of the <strong>cell cycle </strong>and <strong>do not </strong>have a direct role in <strong>immune responses or signaling</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Toll-like receptors </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are <strong>membrane proteins </strong>that recognize a variety of <strong><em>microbe-derived molecules </em></strong>and stimulate <strong>innate immune </strong>responses against the<strong> microbes</strong>. These derive there name due to<strong> homology to a <em>Drosophila </em>protein </strong>called &lsquo;Toll&rsquo;. The <strong>Toll-like receptors </strong>are expressed on many <strong>immune cells of the body. </strong><em><strong>Signaling by Toll-like receptors </strong>result in the<strong> activation of transcription factors notably NF-&kappa;</strong></em></span><strong><em><span style=\"font-family:Symbol\">b</span></em><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></em></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Robbins 10<sup>th</sup>/ 187 </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 56815,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14214,
    "choices": [
      {
        "id": 56817,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-2 </span></span></span></p>"
      },
      {
        "id": 56818,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-4 </span></span></span></p>"
      },
      {
        "id": 56819,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-5 </span></span></span></p>"
      },
      {
        "id": 56820,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-10 </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of a cell-mediated immune response, a 30-year-old patient with chronic granulomatous disease is being evaluated for cytokine profiles to assess T-helper cell function. Which cytokine is predominantly expected to be produced by T-helper type 1 (TH1) cells in this patient?</span></span></span></p>",
    "unique_key": "Q4294292",
    "question_audio": null,
    "question_video": null,
    "map_id": 31833,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) IL-2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper cells </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be divided in <strong>three distinct type</strong>s on the basis of <strong>different cytokines they produce. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper &ndash; 1 (TH1) secretes: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2 and interferon y</strong>, important for<strong> type IV hypersensitivity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-helper &ndash; 2 (TH1) secretes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-4, IL-5,</strong> important for type I hypersensitivity reaction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TH 17 cells: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secretes: <strong>IL-17, IL-22</strong>, these cells defend against <strong>extracellular bacteria and fungi.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2 </strong>is a cytokine produced by<strong> TH1 cells </strong>and is crucial for the <strong>growth, proliferation, and differentiation of T cells.</strong> It is also involved in the <strong>activation of natural killer cells </strong>and is essential for<strong> type IV hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>IL-4</strong> is characteristic of<strong> TH2 cells</strong> and is vital in <strong>humoral immunity. </strong>It promotes the differentiation of<strong> B cells into plasma cells </strong>and class switching to<strong> IgE</strong>, which is important for<strong> type I hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-5 </strong>is another cytokine produced by <strong>TH2 cells</strong>, promoting <strong>growth and differentiation of B cells</strong>. It also stimulates the <strong>production and activation of eosinophils</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IL-10 </strong>is an <strong>anti-inflammatory cytokine </strong>that can be produced by <strong>various cells, including some TH2 cells, and regulatory T cells</strong>. It is known to inhibit the synthesis of <strong>pro-inflammatory cytokines and can downregulate TH1 responses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-2</strong>, is this <strong>cytokine </strong>that is primarily produced by <strong>TH1 cells </strong>and is integral to <strong>cell-mediated immune responses</strong>, particularly in the defense against<strong> intracellular pathogens </strong>and in mediating<strong> type IV hypersensitivity reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 198) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 56817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14119,
    "choices": [
      {
        "id": 56437,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis </span></span></span></p>"
      },
      {
        "id": 56438,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis </span></span></span></p>"
      },
      {
        "id": 56439,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histoplasmosis </span></span></span></p>"
      },
      {
        "id": 56440,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin&#39;s Lymphoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with erythema nodosum and polyarthralgia. Chest x-ray reveals bilateral hilar lymphadenopathy. Biopsy of the lymph nodes shows non-caseating granulomas. What is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q1960663",
    "question_audio": null,
    "question_video": null,
    "map_id": 31834,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Sarcoidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sarcoidosis</strong> is a <strong>systemic inflammatory disease </strong>that can affect<strong> multiple organs, including the lungs, lymph nodes, skin, and joints.</strong> <strong>Erythema nodosum and polyarthralgia </strong>are common <strong>extra-pulmonary manifestations of sarcoidosis</strong>. The presence of <strong>non-caseating granulomas in the lymph nodes and bilateral hilar lymphadenopathy </strong>supports the diagnosis of sarcoidosis in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>multisystem inflammatory disease </strong>characterized by <strong>non-caseating granulomas in multiple organs, </strong>including the <strong>lymph nodes. Bilateral hilar lymphadenopathy and erythema nodosum </strong>are classic presentations, along with<strong> pulmonary involvement and arthralgia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tuberculosis,&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">caused by <strong>Mycobacterium tuberculosis</strong>, typically presents with<strong> caseating granulomas</strong>, not non-caseating. It can cause similar symptoms and chest radiograph findings, but the<strong> granulomas in tuberculosis usually exhibit central necrosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Histoplasmosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>fungal infection </strong>that can cause<strong> granulomatous inflammation</strong>. It often presents with symptoms similar to<strong> tuberculosis </strong>and can affect the <strong>lungs and lymph nodes</strong>. However, it is more commonly associated with <strong>caseating granulomas and typically occurs in endemic areas</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hodgkin&#39;s lymphoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a type of lymphoma that can present with <strong>lymphadenopathy</strong>; however, it is diagnosed by the presence of <strong>Reed-Sternberg cells in the lymph nodes</strong>, not non-caseating granulomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This diagnosis of<strong> sarcoidosis is supported </strong>by the clinical presentation of<strong> erythema nodosum, polyarthralgia, bilateral hilar lymphadenopathy, and biopsy findings of non-caseating granulomas. </strong></span></span></span></p>",
    "correct_choice_id": 56438,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14121,
    "choices": [
      {
        "id": 56445,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune system dysfunction </span></span></span></p>"
      },
      {
        "id": 56446,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genetic defect in the NADPH oxidase enzyme </span></span></span></p>"
      },
      {
        "id": 56447,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic exposure to environmental toxins</span></span></span></p>"
      },
      {
        "id": 56448,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic viral infection</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female presents with a painful and tender nodule on her lower leg. She reports a history of travel to an endemic area for leprosy and was treated successfully. A biopsy of the lesion shows a granulomatous inflammation with giant cells. What is the pathophysiology underlying this patient&#39;s condition?</span></span></p>",
    "unique_key": "Q9212738",
    "question_audio": null,
    "question_video": null,
    "map_id": 31835,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Immune system dysfunction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulomatous inflammation </strong>can occur as a result of<strong> immune system dysfunction</strong>, particularly in response to intracellular pathogens such as <strong>mycobacteria and leprosy</strong>. In these conditions, the <strong>host immune response leads to the formation of granulomas, </strong>which are aggregates of <strong>activated macrophages and other immune cells </strong>that wall off the infection. The giant cells present in these granulomas are formed by the <strong>fusion of epithelioid cells</strong>, which are activated macrophages that have taken up and processed the antigen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leprosy </strong>is caused by the bacterium <strong>Mycobacterium leprae</strong>, which leads to an<strong> immune response </strong>that can result in<strong> granuloma formation</strong>. The condition represents an i<strong>mmune system response </strong>trying to contain the<strong> pathogen</strong>, which may be<strong> dysfunctional or overactive, leading to tissue damage and the formation of nodules</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Enzyme A genetic defect in NADPH oxidase </strong>results in<strong> chronic granulomatous disease</strong>, a condition where <strong>phagocytes can ingest </strong>but<strong> cannot kill certain bacteria and fungi due to a lack of reactive oxygen </strong>species production. This is different from the immune response to leprosy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Environmental toxins </strong>can lead to various forms of <strong>inflammation and tissue damage</strong>, but they are not typically associated with granulomatous inflammation due to an infectious disease like leprosy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Chronic viral infections </strong>can lead to persistent<strong> immune responses </strong>and sometimes<strong> granulomatous inflammation</strong>; however, <strong>leprosy is a bacterial infection</strong>, not viral.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of<strong> leprosy, granulomatous inflammation </strong>is a result of the body&#39;s immune response to the<strong> intracellular pathogen, Mycobacterium leprae</strong>. The formation of <strong>granulomas</strong>, often containing <strong>giant cells</strong>, is a way the <strong>immune system</strong> attempts to contain the <strong>pathogen. </strong></span></span></span></p>",
    "correct_choice_id": 56445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14135,
    "choices": [
      {
        "id": 56501,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor necrosis factor-alpha (TNF-&alpha;) </span></span></span></p>"
      },
      {
        "id": 56502,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-6 (IL-6) </span></span></span></p>"
      },
      {
        "id": 56503,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-1 beta (IL-1</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;</span><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">) </span></span></span></p>"
      },
      {
        "id": 56504,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-10 (IL-10)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female presents with joint pain, stiffness, and swelling in her hands and wrists. She reports a history of psoriasis and has been diagnosed with psoriatic arthritis. Which cytokine is most likely involved in the pathogenesis of her disease?</span></span></p>",
    "unique_key": "Q8133223",
    "question_audio": null,
    "question_video": null,
    "map_id": 31836,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tumor necrosis factor-alpha (TNF-&alpha;)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor necrosis factor-alpha (TNF-&alpha;). </strong>TNF-&alpha; is a<strong> pro-inflammatory cytokine </strong>that plays a key role in the<strong> pathogenesis of psoriatic arthritis. </strong>It is produced by <strong>immune cells, including macrophages and T cells, and promotes the recruitment of inflammatory cells to the joints</strong>, leading to <strong>synovial inflammation and destruction of cartilage and bone</strong>. Drugs that <strong>target TNF-&alpha;,</strong> such as <strong>infliximab and adalimumab, </strong>have been shown to be effective in the treatment of<strong> psoriatic arthritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; </strong>is indeed a key <strong>pro-inflammatory cytokine in the pathogenesis of psoriatic arthritis. </strong>It promotes <strong>inflammation in the joints and skin</strong>, leading to the symptoms of <strong>arthritis and psoriasis</strong>. <strong>TNF-&alpha; inhibitors </strong>are a mainstay of treatment for <strong>moderate to severe cases, </strong>highlighting its critical role in the <strong>disease process</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IL-6 is another <strong>pro-inflammatory cytokine </strong>involved in the <strong>immune response and inflammation</strong>. While it plays a role in the <strong>pathophysiology </strong>of various arthritic conditions, including <strong>rheumatoid arthritis,</strong> <strong>TNF-&alpha; is more specifically targeted in the treatment of psoriatic arthritis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IL-1&beta; is a<strong> pro-inflammatory cytokine</strong> that contributes to<strong> inflammation and cellular damage </strong>in many <strong>autoimmune</strong> <strong>diseases. </strong>Like<strong> TNF-&alpha; and IL-6</strong>, it is involved in the <strong>inflammatory cascade</strong> but is not as prominent a target in psoriatic arthritis as TNF-&alpha;.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IL-10</strong> is an <strong>anti-inflammatory cytokine </strong>that helps to regulate the <strong>immune response and dampen inflammation</strong>. It&#39;s typically not the target in psoriatic arthritis treatment strategies but rather part of the <strong>body&#39;s natural mechanism to control excessive inflammation</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; i</strong>s critically involved in the<strong> inflammatory processes of psoriatic arthritis </strong>and is a primary target for <strong>therapeutic intervention</strong>. <strong>Biologic agents</strong> that inhibit TNF-&alpha;, such as<strong> infliximab</strong>, have been effective in <strong>reducing the inflammation and joint damage associated with psoriatic arthritis</strong>. </span></span></span></p>",
    "correct_choice_id": 56501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 16854,
    "choices": [
      {
        "id": 67376,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical carcinoma</span></span></span></p>"
      },
      {
        "id": 67377,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral carcinoma</span></span></span></p>"
      },
      {
        "id": 67378,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngeal papillomatosis.</span></span></span></p>"
      },
      {
        "id": 67379,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anorectal carcinoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are caused by lethal strains of HPV, except:</span></span></p>",
    "unique_key": "Q1096283",
    "question_audio": null,
    "question_video": null,
    "map_id": 31848,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Laryngeal papillomatosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is commonly caused by <strong>HPV types 6 and 11</strong>, which are considered <strong>low-risk types</strong>. While it can <strong>cause </strong>significant <strong>morbidity </strong>due to <strong>recurrent benign papillomas </strong>in the <strong>larynx</strong>, it is not typically associated with the development of cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cervical carcinoma:</strong> <strong>Persistent infection </strong>with these <strong>high-risk HPV types </strong>especially <strong>HPV 16, 18, 31 and 33 </strong>, can lead to the <strong>progression of cervical dysplasia </strong>to invasive carcinoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Oral carcinoma:</strong> <strong>HPV infection</strong>, especially with <strong>types 16 and 18</strong>, has been <strong>linked to the development of oral </strong>and <strong>oropharyngeal cancers</strong>, particularly in the tonsillar and base of the tongue areas.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Anorectal carcinoma:</strong> <strong>High-risk HPV types</strong>, including <strong>16 and 18</strong>, are implicated in the <strong>development of anal </strong>and <strong>anorectal carcinomas</strong>. These cancers are more prevalent in individuals with persistent HPV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is typically caused by the <strong>low-risk human papillomavirus </strong>(HPV) <strong>types 6 and 11</strong>, which are <strong>not commonly associated with malignancy</strong>. In contrast, high-risk HPV types, particularly 16 and 18, are associated with an increased risk of developing cancers such as cervical carcinoma, oral carcinoma, and anorectal carcinoma.</span></span></span></p>",
    "correct_choice_id": 67378,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 16855,
    "choices": [
      {
        "id": 67380,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E6 </span></span></span></p>"
      },
      {
        "id": 67381,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E7</span></span></span></p>"
      },
      {
        "id": 67382,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMP1 </span></span></span></p>"
      },
      {
        "id": 67383,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tax</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents with a history of persistent genital warts. Upon further investigation, it is found that the Human Papillomavirus (HPV) responsible for her condition produces a protein that interacts with the Retinoblastoma (Rb) tumor suppressor protein, leading to its degradation. Which of the following HPV proteins is involved in this process?</span></span></p>",
    "unique_key": "Q4607619",
    "question_audio": null,
    "question_video": null,
    "map_id": 31850,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) E7 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>E7 protein </strong>produced by <strong>Human Papillomavirus </strong>(HPV) interacts with the <strong>Retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation or inactivation</strong>. This <strong>interaction </strong>disrupts the <strong>regulation of cell cycle progression </strong>and <strong>promotes cell proliferation</strong>, contributing to the oncogenic potential of HPV.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. E6&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>protein </strong>of <strong>HPV </strong>interacts with <strong>cellular proteins</strong>, including <strong>p53</strong>, leading to its <strong>degradation</strong>, which can disrupt cell cycle control and apoptosis regulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. LMP1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Latent Membrane Protein 1 </strong>is a <strong>protein </strong>produced by the <strong>Epstein-Barr virus</strong>. It plays a role in oncogenesis by activating signaling pathways involved in cell proliferation and survival.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tax&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>protein </strong>produced by the <strong>Human T-cell Leukemia Virus type 1 </strong>(HTLV-1), not HPV. Tax protein is known to interact with various cellular proteins and pathways, promoting cell proliferation and inhibiting apoptosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HPV E7 protein </strong>has a <strong>role in promoting cellular proliferation </strong>and <strong>potential oncogenesis </strong>through <strong>interaction </strong>with the <strong>retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p324</span></strong></span></span></p>",
    "correct_choice_id": 67381,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14162,
    "choices": [
      {
        "id": 56609,
        "text": "<p><span style=\"font-size:12pt;\">Macrophages</span></p>"
      },
      {
        "id": 56610,
        "text": "<p><span style=\"font-size:12pt;\">Dendritic cells</span></p>"
      },
      {
        "id": 56611,
        "text": "<p><span style=\"font-size:12pt;\">CD4+ T cells</span></p>"
      },
      {
        "id": 56612,
        "text": "<p><span style=\"font-size:12pt;\">Mast cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In a clinical case where a patient presents with contact dermatitis after using a new cosmetic product, which cell type is most likely responsible for the patient's delayed-type hypersensitivity (DTH) reaction?</span></p>",
    "unique_key": "Q2431725",
    "question_audio": null,
    "question_video": null,
    "map_id": 31868,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) CD4+ T cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CD4+ T cells: </strong>(CD4+ T cells) can be involved in<strong> DTH reactions</strong>, particularly those against <strong>intracellular pathogens</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Macrophages:</strong> Macrophages are involved in <strong>DTH reactions </strong>as effector cells that respond to <strong>cytokines produced</strong> <strong>by T-helper cells. </strong>They are NOT the initial responders but are critical for the<strong> amplification and persistence of the reaction.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Dendritic Cells:</strong> Dendritic cells are <strong>antigen-presenting cells</strong> that are crucial for initiating a <strong>DTH reaction.</strong> They <strong>capture,</strong> <strong>process, and present antigens</strong> on their surface to T cells but are <strong>NOT the cells </strong>that directly mediate the <strong>DTH response.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Mast Cells:</strong> Mast cells are associated with <strong>immediate hypersensitivity reactions</strong>, such as <strong>allergies and anaphylaxis, </strong>due to their release of<strong> histamine and other mediators</strong>.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Classic DTH reaction is mainly driven by<strong> CD4+ T-helper cells, particularly the Th1 subtype.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key cells involved:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ijrNqCg.png\" width=\"1086\" height=\"305\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins 10th/214</strong></span></p>",
    "correct_choice_id": 56611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14164,
    "choices": [
      {
        "id": 56617,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I </span></span></span></p>"
      },
      {
        "id": 56618,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II </span></span></span></p>"
      },
      {
        "id": 56619,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III </span></span></span></p>"
      },
      {
        "id": 56620,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man with no prior allergies receives penicillin for a bacterial infection. Two days later, he presents with wheezing and laboratory tests showing hemolysis with a positive direct Coombs test. Which hypersensitivity reaction is most likely responsible for this patient&#39;s presentation?</span></span></span></p>",
    "unique_key": "Q7871778",
    "question_audio": null,
    "question_video": null,
    "map_id": 31869,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Type II</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II Hypersensitivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type II hypersensitivity reactions are<strong> antibody-mediated and target-specific cells or tissues</strong>. The classic mechanism involves<strong> IgG antibodies directed against cell surface antigens</strong>, often leading to conditions such as<strong> hemolytic anemia, as seen in drug-induced hemolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Type I Hypersensitivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type I hypersensitivity reactions are<strong> immediate reactions mediated by IgE antibodies. </strong>Typical manifestations include<strong> urticaria, angioedema, asthma, and anaphylaxis, </strong>usually occurring within <strong>minutes to hours </strong>after exposure to the <strong>allergen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Type III Hypersensitivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type III hypersensitivity reactions are <strong>immune complex-mediated</strong>. They occur when <strong>antigens and IgG antibodies form immune complexes </strong>that deposit in various tissues, causing inflammation and tissue damage, such as in s<strong>erum sickness or certain glomerulonephritides.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Type IV Hypersensitivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type IV hypersensitivity reactions are <strong>delayed-type reactions mediated by T cells</strong>. Symptoms typically appear<strong> 48-72 hours after exposure to the antigen</strong>, as seen in<strong> contact dermatitis or a positive tuberculosis skin test</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s <strong>hemolysis following penicillin </strong>administration suggests a <strong>type II hypersensitivity reaction, </strong>where the drug acts as a <strong>hapten, binding to red blood cell membranes </strong>and <strong>inducing an antibody response against the drug-protein complex</strong>.</span></span></p>",
    "correct_choice_id": 56618,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 14166,
    "choices": [
      {
        "id": 56625,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin D2</span></span></span></p>"
      },
      {
        "id": 56626,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></span></span></p>"
      },
      {
        "id": 56627,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine</span></span></span></p>"
      },
      {
        "id": 56628,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young boy presents to the emergency department with sudden shortness of breath. He also complains of abdominal pain and few episodes of vomiting. In the hospital, he slowly developed a rash on his chest, arms, and legs. His breathing became faster with audible wheezing. On physical examination, he had hypotension and tachycardia. A rash is on his right arm, as shown in the image. After being administered appropriate treatment, the boy improves significantly, and he is able to breathe comfortably. Which of the following is the best marker that could be measured in the serum of this boy to help establish a definitive diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/picture3.jpg\" style=\"height:180px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2523541",
    "question_audio": null,
    "question_video": null,
    "map_id": 31870,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Tryptase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tryptase is an enzyme released from mast cells during anaphylaxis. Its serum levels can be elevated for several hours following an <strong>anaphylactic event,</strong> making it a useful marker for confirming the<strong> diagnosis when measured during the acute phase</strong> and again at <strong>baseline (&ge;24 hours later).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Prostaglandin D2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Prostaglandin D2 is one of many mediators released during an <strong>allergic reaction</strong>, but it is<strong> not </strong>typically measured in the acute setting due to its<strong> short half-life and the availability of more stable markers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\\Option B: Serotonin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Serotonin can be involved in <strong>allergic reactions and contributes to the pathophysiology </strong>of certain types of <strong>hypersensitivity</strong>. However, it is <strong>not the primary marker used for the diagnosis of anaphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Histamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Histamine is a primary mediator in <strong>allergic reactions and is released during anaphylaxis</strong>. While histamine levels can<strong> rise rapidly </strong>during anaphylaxis, its <strong>short half-life</strong> in the circulation makes it a less reliable marker than tryptase for post-event testing.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The measurement of <strong>serum tryptase is the gold standard for confirming a diagnosis of anaphylaxis. </strong>It should be measured during the <strong>acute phase of the reaction</strong> and compared to a baseline level taken 24 hours or more after the event. </span></span></span></span></span></p>",
    "correct_choice_id": 56628,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 14168,
    "choices": [
      {
        "id": 56633,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hypersensitivity reaction</span></span></span></p>"
      },
      {
        "id": 56634,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II hypersensitivity reaction</span></span></span></p>"
      },
      {
        "id": 56635,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III hypersensitivity reaction</span></span></span></p>"
      },
      {
        "id": 56636,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV hypersensitivity reaction</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female presents with a history of itching, hives, and difficulty breathing after eating a peanut butter sandwich. On examination, she has wheezing and diffuse urticaria. Which of the following hypersensitivity reactions is most likely responsible for her symptoms?</span></span></span></p>",
    "unique_key": "Q1598309",
    "question_audio": null,
    "question_video": null,
    "map_id": 31871,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Type I hypersensitivity reaction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I Hypersensitivity Reaction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type I hypersensitivity, also known as an<strong> immediate hypersensitivity reaction, is IgE mediated </strong>and occurs rapidly after exposure to an allergen, such as<strong> peanuts in this patient</strong>. It is characterized by symptoms like <strong>urticaria (hives), angioedema, and anaphylaxis, which includes respiratory distress.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Type II Hypersensitivity Reaction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type II hypersensitivity is <strong>antibody-mediated </strong>and usually <strong>targets cellular antigens, </strong>leading to conditions like<strong> hemolytic anemia, thrombocytopenia, and certain drug reactions. </strong>It is <strong>not </strong>associated with <strong>allergies to foods.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Type III Hypersensitivity Reaction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type III hypersensitivity involves<strong> immune complex deposition </strong>and is implicated in conditions like <strong>serum sickness and certain glomerulonephritides. </strong>It is not typically involved in reactions to foods.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Type IV Hypersensitivity Reaction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type IV hypersensitivity, or <strong>delayed-type hypersensitivity</strong>, is <strong>T cell-mediated and occurs 48&ndash;72 hours after exposure to an antigen</strong>, as seen in contact<strong> dermatitis or a positive tuberculosis skin test</strong>. It does not cause immediate symptoms like those seen in anaphylaxis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms of <strong>itching, hives, and difficulty breathing immediately following ingestion of a known allergen are indicative of a Type I hypersensitivity reaction</strong>. This reaction is mediated by<strong> IgE antibodies specific to the allergen</strong>, leading to mast <strong>cell degranulation and the release of histamine and other mediators</strong>. </span></span></span></span></span></p>",
    "correct_choice_id": 56633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 14170,
    "choices": [
      {
        "id": 56641,
        "text": "<p><span style=\"font-size:12pt;\">IgA vasculitis -Type III hypersensitivity</span></p>"
      },
      {
        "id": 56642,
        "text": "<p><span style=\"font-size:12pt;\">Post streptococcal glomerulonephritis-Immune complex disease</span></p>"
      },
      {
        "id": 56643,
        "text": "<p><span style=\"font-size:12pt;\">Schick test - Delayed Hypersensitivity</span></p>"
      },
      {
        "id": 56644,
        "text": "<p><span style=\"font-size:12pt;\">Mismatched blood transfusion - Type II hypersensitivity</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In each of the following clinical scenarios, a specific type of hypersensitivity reaction is implicated. Identify the INCORRECT pairing:</span></p>",
    "unique_key": "Q7537699",
    "question_audio": null,
    "question_video": null,
    "map_id": 31872,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Schick test - Delayed Hypersensitivity</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Schick test is type 3 hypersensitivity reaction whereas delayed hypersensitivity is type 4 reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Schick Test - Delayed Hypersensitivity:</strong> The Schick test, which was historically used to determine susceptibility to diphtheria, is based on a toxin-antitoxin reaction and does not involve delayed hypersensitivity. Therefore, this is the incorrect pairing as delayed hypersensitivity is a Type IV reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: IgA Vasculitis - Type III Hypersensitivity:</strong> IgA vasculitis, formerly known as Henoch-Sch\u00f6nlein purpura, is characterized by IgA-dominant immune complex deposition, thus aligning with a Type III hypersensitivity reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Post Streptococcal Glomerulonephritis - Immune Complex Disease:</strong> Post-streptococcal glomerulonephritis is a classic example of an immune complex disease, where antibodies against streptococcal antigens form complexes that deposit in the glomeruli, representing a Type III hypersensitivity reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Mismatched Blood Transfusion - Type II Hypersensitivity:</strong> Mismatched blood transfusion reactions occur when the recipient's antibodies bind to antigens on the donor red blood cells, leading to hemolysis. This is a classic Type II hypersensitivity reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The Schick test is not a delayed Type IV hypersensitivity reaction; it is a demonstration of the presence or absence of immunity to diphtheria toxin and is a form of Type III hypersensitivity</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gjdDlyp.png\" width=\"1379\" height=\"429\"></span></p>",
    "correct_choice_id": 56643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14210,
    "choices": [
      {
        "id": 56801,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic antibody production</span></span></span></p>"
      },
      {
        "id": 56802,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delayed-type hypersensitivity</span></span></span></p>"
      },
      {
        "id": 56803,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposition of anti gliadin antibodies</span></span></span></p>"
      },
      {
        "id": 56804,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposition of circulating immune complexes</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old girl presents to his family physician for treatment of oozing blisters and crusts on her wrists after wearing some artificial jewellery. Which of the following best describes the pathogenesis of these skin lesions?</span></span></span></p>",
    "unique_key": "Q3065038",
    "question_audio": null,
    "question_video": null,
    "map_id": 31867,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Delayed type hypersensitivity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact dermatitis </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a<strong> type IV hypersensitivity reaction</strong>. This<strong> T-lymphocyte&ndash;mediated allergic </strong>condition presents as <strong>urticaria and bullous eruption</strong>. <strong>Blisters rupture and heal with crusts</strong>, usually <strong>without scarring. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposition of <strong>anti-gliadin antibodies </strong>(choice C) occurs in patients with <strong>dermatitis herpetiformis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delayed-type hypersensitivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Delayed-type hypersensitivity (DTH) is a<strong> type IV hypersensitivity reaction mediated by T cells</strong>, which occurs <strong>hours to days</strong> after <strong>antigen exposure </strong>and is the primary mechanism in <strong>contact dermatitis, </strong>as seen with reactions to jewellery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Cytotoxic antibody production:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cytotoxic antibodies, typically <strong>IgG or IgM, </strong>mediate destruction of <strong>target cells by complement activation </strong>or<strong> antibody-dependent cellular cytotoxicity, </strong>not typically involved in contact dermatitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Deposition of anti-gliadin antibodies:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Anti-gliadin antibodies are associated with <strong>celiac disease </strong>and can be involved in <strong>dermatitis herpetiformis </strong>but are not related to contact dermatitis from jewelry.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Deposition of circulating immune complexes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immune complex </strong>deposition is a feature of <strong>type III hypersensitivity reactions</strong>, which involve<strong> antigen-antibody complexes </strong>that deposit in <strong>various tissues</strong>, not the skin reaction seen in contact dermatitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Contact dermatitis </strong>is a classic example of a<strong> delayed-type hypersensitivity reaction</strong>, a <strong>type IV hypersensitivity, </strong>where upon exposure to <strong>an allergen</strong>, <strong>T lymphocytes </strong>mediate an <strong>allergic response </strong>leading to skin lesions such as<strong> urticaria and blisters that rupture and heal with crusts.</strong></span></span></span></p>",
    "correct_choice_id": 56802,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 14877,
    "choices": [
      {
        "id": 59468,
        "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
      },
      {
        "id": 59469,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      },
      {
        "id": 59470,
        "text": "<p><span style=\"font-size:12.0pt;\">Byssinosis</span></p>"
      },
      {
        "id": 59471,
        "text": "<p><span style=\"font-size:12.0pt;\">Berylliosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is associated with hypersensitive pneumonitis?</span></p>",
    "unique_key": "Q1551744",
    "question_audio": null,
    "question_video": null,
    "map_id": 31873,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Byssinosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Hypersensitivity pneumonitis </strong>(also called <strong>allergic alveolitis</strong>) is an inflammatory lung disease caused by the<strong> immune system's response </strong>to the <strong>inhalation of various organic dusts or antigens</strong>.<strong> Byssinosis </strong>is indeed associated with<strong> hypersensitivity pneumonitis</strong>. <strong>Byssinosis</strong>, also known as \"<strong>brown lung disease\" or \"Monday fever,\" </strong>is an<strong> occupational lung disease </strong>caused by the <strong>inhalation of cotton, flax, or hemp dust. </strong>It is a type <i><strong>III + IV hypersensitivity reaction</strong></i>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:&nbsp;Silicosis:&nbsp;</strong>Silicosis is<strong> not </strong>associated with <strong>hypersensitivity pneumonitis. </strong>It is a lung disease caused by the<strong> inhalation of crystalline silica dust.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;Asbestosis:&nbsp;</strong>Asbestosis is<strong> not </strong>associated with <strong>hypersensitivity pneumonitis</strong>. It is caused by the <strong>inhalation of asbestos fibers </strong>and is characterized by <strong>interstitial fibrosis in the lungs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:&nbsp;Berylliosis:&nbsp;Berylliosis </strong>is associated with<strong> hypersensitivity pneumonitis</strong>. It is an<strong> inflammatory lung disease </strong>caused by exposure to <strong>beryllium, </strong>a metal used in various <strong>industries.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Byssinosis, </strong>an <strong>occupational lung </strong>disease caused by the inhalation of <strong>cotton, flax, or hemp dust</strong>, is associated with <strong>hypersensitivity pneumonitis</strong>, presenting as a mixed <strong>type III and IV hypersensitivity reaction.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Mnemonic to remember HP causes:</strong> <strong>\"Farmers Buy Many Birds\"</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>F</strong> \u2013 Farmer\u2019s lung</span></li><li><span style=\"font-size:16px;\"><strong>B</strong> \u2013 Byssinosis</span></li><li><span style=\"font-size:16px;\"><strong>M</strong> \u2013 Malt worker\u2019s lung</span></li><li><span style=\"font-size:16px;\"><strong>B</strong> \u2013 Bird fancier\u2019s lung</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XkhO8jm.png\" width=\"1448\" height=\"810\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 690)</strong></span></p>",
    "correct_choice_id": 59470,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 14169,
    "choices": [
      {
        "id": 56637,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affects males and females equally </span></span></span></p>"
      },
      {
        "id": 56638,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal and CNS involvement is uncommon</span></span></span></p>"
      },
      {
        "id": 56639,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti histone antibody levels are low </span></span></span></p>"
      },
      {
        "id": 56640,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The disease remits after withdrawal of the offending drug</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In evaluating a patient with a suspected diagnosis of drug-induced lupus erythematosus (DILE), which of the following statements is INCORRECT?</span></span></span></p>",
    "unique_key": "Q2833636",
    "question_audio": null,
    "question_video": null,
    "map_id": 31881,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Anti histone antibody levels are low</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-histone antibody levels are low:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong>. In DILE, there is typically a<strong> high level of anti-histone antibodies, </strong>which is a<strong> hallmark of the condition </strong>and helps differentiate it from <strong>idiopathic SLE</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Affects males and females equally:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> DILE does not demonstrate the same <strong>female predominance </strong>as systemic lupus erythematosus (SLE). Both males and females are affected equally.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Renal and CNS involvement is uncommon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Unlike SLE, DILE typically <strong>spares the kidneys and central nervous system</strong>, with these organ systems being less commonly involved.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: The disease remits after withdrawal of the offending drug:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> One of the key features of <strong>DILE </strong>is that symptoms usually resolve upon <strong>withdrawal of the offending drug</strong>, differentiating it from<strong> idiopathic SLE</strong>, which is a chronic condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Drug-induced lupus erythematosus </strong>is characterized by <strong>high levels of anti-histone antibodies</strong>, and unlike<strong> idiopathic SLE</strong>, it affects <strong>males and females equally, renal and CNS involvement are uncommon</strong>, and the condition usually remits after<strong> withdrawal of the offending drug</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference Robbins 10<sup>th</sup>/229</span></strong></span></span></p>",
    "correct_choice_id": 56639,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14173,
    "choices": [
      {
        "id": 56653,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molecular mimicry</span></span></span></p>"
      },
      {
        "id": 56654,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal B cell activation </span></span></span></p>"
      },
      {
        "id": 56655,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Expressing sequestrated antigens </span></span></span></p>"
      },
      {
        "id": 56656,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigenic cross reactivity </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with Epstein-Barr virus (EBV) infection presenting with symptoms of autoimmunity, which mechanism is most likely contributing to the production of autoantibodies?</span></span></span></p>",
    "unique_key": "Q5493864",
    "question_audio": null,
    "question_video": null,
    "map_id": 31882,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Polyclonal B cell activation </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal B cell activation is caused by<strong> EBV and HIV </strong>resulting in production of <strong>autoantibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal B cell activation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> EBV infection </strong>is associated with <strong>polyclonal B cell activation. </strong>This uncontrolled activation can lead to the production of a<strong> wide array of antibodies, </strong>including <strong>autoantibodies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Molecular Mimicry:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Molecular mimicry involves an<strong> infectious agent </strong>sharing <strong>epitopes </strong>with the host, leading to an <strong>immune response </strong>that <strong>cross-reacts with self-tissues. </strong>It is a known mechanism in certain <strong>autoimmune diseases </strong>but is not<strong> the primary mechanism </strong>by which <strong>EBV induces autoimmunity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Expressing sequestrated antigens:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Sequestered antigens, normally hidden from the<strong> immune system,</strong> may become exposed due to t<strong>issue damage or other pathological processes</strong>, which could induce an <strong>autoimmune response.</strong> However, this is not typically associated with EBV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Antigenic Cross-reactivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Antigenic cross-reactivity refers to an <strong>immune response against one antigen </strong>that reacts with a different but <strong>structurally similar antigen</strong>. While it can contribute to <strong>autoimmunity, </strong>it is not the primary process implicated in EBV-related autoimmunity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The development of <strong>autoimmunity </strong>in the context of <strong>EBV infection </strong>is primarily associated with <strong>polyclonal B cell activation</strong>, leading to the production of <strong>autoantibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 220) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em> </em></strong></span></span></p>",
    "correct_choice_id": 56654,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14174,
    "choices": [
      {
        "id": 56657,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic lupus erythematosus </span></span></span></p>"
      },
      {
        "id": 56658,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma </span></span></p>"
      },
      {
        "id": 56659,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid arthritis </span></span></span></p>"
      },
      {
        "id": 56660,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histiocytosis </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">14-year-old girl experiences episodes of pallor, pain, and cyanosis in her extremities upon exposure to cold. This condition often precedes the development of which systemic disease, known for its cutaneous manifestations and association with such vascular phenomena?</span></span></span></p>",
    "unique_key": "Q5103383",
    "question_audio": null,
    "question_video": null,
    "map_id": 31883,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Scleroderma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma (Systemic Sclerosis):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Scleroderma is well known for <strong>skin thickening and Raynaud&#39;s phenomenon, </strong>which is seen in virtually all patients and often precedes other symptoms, making it the most likely diagnosis associated with these symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Systemic Lupus Erythematosus (SLE):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SLE is a <strong>chronic autoimmune disease </strong>with various clinical presentations,<strong> including Raynaud&#39;s phenomenon</strong>. However, SLE is characterized more by <strong>systemic symptoms </strong>and<strong> less by the cutaneous changes described.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Rheumatoid Arthritis (RA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> RA is a <strong>chronic inflammatory disease </strong>primarily affecting the <strong>joints. </strong>While vascular symptoms can occur, they are <strong>not as prominent </strong>as the <strong>articular manifestations </strong>and not typically preceded by Raynaud&#39;s phenomenon.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Histiocytosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Histiocytosis refers to a <strong>group of disorders </strong>characterized by the <strong>proliferation of histiocytes</strong>. It <strong>does not commonly </strong>present with<strong> Raynaud&#39;s phenomenon </strong>as an initial symptom.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Raynaud&#39;s phenomenon</strong>, characterized by episodic<strong> vasoconstriction of the arteries and arterioles of the extremities</strong>, is commonly associated with <strong>scleroderma </strong>and can precede <strong>other symptoms of the disease</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 228-229) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 56658,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14183,
    "choices": [
      {
        "id": 56693,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PTPN22</span></span></span></p>"
      },
      {
        "id": 56694,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAS</span></span></span></p>"
      },
      {
        "id": 56695,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADD</span></span></span></p>"
      },
      {
        "id": 56696,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NOD like receptor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with chronic nonmalignant lymphoproliferation, autoimmune cytopenias, and a family history suggestive of a genetic syndrome. Genetic testing for which of the following genes is most likely to confirm the diagnosis?</span></span></span></p>",
    "unique_key": "Q5572089",
    "question_audio": null,
    "question_video": null,
    "map_id": 31877,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) FAS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Self-reactive B cells </strong>are killed by<strong> Fas L on T cells engaging Fas on the B </strong>cells. Mutations in<strong> Fas or Fas L in mice and humans result in an autoimmune disease </strong>reminiscent of <strong>human SLE </strong>called the <strong><em>autoimmune lymphoproliferative syndrome (ALPS)</em></strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The FAS gene encodes a <strong>cell surface receptor </strong>important for the <strong>apoptotic death of cells</strong>, including <strong>self-reactive B and T lymphocytes</strong>. Mutations in the FAS gene can<strong> lead to ALPS, </strong>characterized by accumulation of<strong> lymphocytes and increased risk of autoimmune disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: PTPN22:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The PTPN22 gene encodes a<strong> tyrosine phosphatase involved in T cell receptor signaling. </strong>Mutations in this gene are associated with various autoimmune conditions, such as <strong>rheumatoid arthritis and type 1 diabetes</strong>, but not typically with <strong>autoimmune lymphoproliferative syndrome (ALPS).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: FADD:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> FADD is an <strong>adaptor protein </strong>involved in the <strong>apoptotic pathway</strong>. While important for <strong>apoptosis</strong>, known mutations in FADD are not classically associated with ALPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: NOD-like Receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> NOD-like receptors are <strong>intracellular sensors of microbial motifs </strong>and<strong> cell stress </strong>that lead to <strong>inflammation, not apoptosis. </strong>Mutations in <strong>NOD-like receptors </strong>are associated with <strong>autoinflammatory syndromes, not ALPS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Autoimmune lymphoproliferative syndrome (ALPS) </strong>is often caused by <strong>mutations in the FAS gene</strong>, which leads to defects in the <strong>apoptotic pathway, </strong>specifically in the <strong>programmed cell death of lymphocytes</strong>. This condition is characterized by<strong> autoimmune manifestations similar to systemic lupus erythematosus (SLE).</strong></span></span></p>",
    "correct_choice_id": 56694,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14196,
    "choices": [
      {
        "id": 56745,
        "text": "<p><span style=\"font-size:12pt;\">Positive SS-A</span></p>"
      },
      {
        "id": 56746,
        "text": "<p><span style=\"font-size:12pt;\">Positive anti-Smith antibody</span></p>"
      },
      {
        "id": 56747,
        "text": "<p><span style=\"font-size:12pt;\">Positive anti-cyclic citrullinated peptide (CCP-IgG)</span></p>"
      },
      {
        "id": 56748,
        "text": "<p><span style=\"font-size:12pt;\">Positive rheumatoid factor</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 26-year-old female presents with complaints of fatigue since 2 months. She has persistent arthralgia of the distal and proximal interphalangeal joints of both hands. Her physical examination is normal and there is no tenderness or deformity of the joints of the hands. A complete blood count is normal and her antinuclear antibody titer is elevated at 1:90. Which of the following additional tests would confirm the diagnosis of lupus erythematosus?</span></p>",
    "unique_key": "Q2855352",
    "question_audio": null,
    "question_video": null,
    "map_id": 31879,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Positive anti-Smith antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Anti-Smith </strong>(B) is<strong> most specific</strong> for <strong>systemic lupus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Positive anti-Smith antibody:</strong> The anti-Smith antibody is<strong> highly specific for SLE</strong>. This<strong> and a positive ANA </strong>would strongly support the<strong> diagnosis of SLE.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Positive SS-A:</strong> SS-A (or Ro) antibodies are associated with <strong>SLE </strong>(presence of the other issues like subacute cutaneous lupus)<strong> and Sj\u00f6gren\u2019s syndrome. </strong>Although they can be present in SLE, they are <strong>not specific to </strong>it, especially when considering the patient's clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Positive anti-cyclic citrullinated peptide (CCP-IgG):</strong> Anti-CCP IgG is<strong> highly specific for rheumatoid arthritis </strong>and is not typically used in the diagnosis of SLE.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Positive rheumatoid factor:</strong> Rheumatoid factor can be positive in a variety of<strong> rheumatologic diseases, including SLE</strong>, but it is <strong>not specific for SLE </strong>and is <strong>more commonly associated with rheumatoid arthritis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When evaluating a patient for SLE, the <strong>anti-Smith antibody test is the most specific serological test </strong>and can <strong>confirm the diagnosis </strong>when the clinical picture is suggestive of the disease.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ANA = screen \u2192 very sensitive but non-specific.</span></li><li><span style=\"font-size:12.0pt;\">Anti-Smith antibody - highly specific for SLE \u2192 confirms diagnosis when present.</span></li><li><span style=\"font-size:12.0pt;\">Anti-dsDNA is also specific and associated with lupus nephritis, but among the choices given, anti-Smith is the classic confirmatory antibody.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref Robbins 10<sup>th</sup>/ 222</strong></span></p>",
    "correct_choice_id": 56746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 14199,
    "choices": [
      {
        "id": 56757,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte</span></span></span></p>"
      },
      {
        "id": 56758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell</span></span></span></p>"
      },
      {
        "id": 56759,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eosinophil</span></span></span></p>"
      },
      {
        "id": 56760,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophil </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of systemic lupus erythematosus (SLE), which cell type is historically known for its role in the formation of lupus erythematosus (LE) cells, a phenomenon once used in the diagnosis of SLE?</span></span></span></p>",
    "unique_key": "Q3489530",
    "question_audio": null,
    "question_video": null,
    "map_id": 31880,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Neutrophil</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lupus erythematosus (LE) cell </strong>is a phagocytic<strong> neutrophil or macrophage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nuclei of damaged cells </strong>react with <strong>ANAs, lose their chromatin pattern</strong>, and become <strong>homogeneous </strong>to produce<strong> LE bodies or hematoxylin bodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phagocytic neutrophils or macrophages engulf the denatured nucleus </strong>of an injured cell. Demonstration of <strong>LE cells in vitro </strong>was used in the <strong>past for the diagnosis of SLE.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> LE cell is a neutrophil</strong> that has<strong> phagocytosed the denatured nucleus of another cell</strong>, which is a characteristic feature seen in<strong> SLE.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lymphocyte:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lymphocytes are primarily involved in <strong>adaptive immune responses </strong>and are <strong>not typically phagocytic cells </strong>associated with the <strong>formation of LE cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Endothelial Cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endothelial cells line <strong>blood vessels </strong>and are<strong> not involved in phagocytosis or the formation of LE cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Eosinophil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Eosinophils are involved in <strong>allergic reactions and parasitic infections </strong>and do not form LE cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LE cells are neutrophils or macrophages </strong>that have <strong>phagocytosed nuclear material</strong>. The demonstration of<strong> LE cells </strong>used to be a <strong>diagnostic test for SLE</strong>, reflecting the <strong>autoantibody-mediated destruction of cells </strong>leading to the presentation of <strong>nuclear antigens to these phagocytes. </strong></span></span></p>",
    "correct_choice_id": 56760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14201,
    "choices": [
      {
        "id": 56765,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mikulicz syndrome</span></span></span></p>"
      },
      {
        "id": 56766,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riedel thyroiditis</span></span></span></p>"
      },
      {
        "id": 56767,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic retroperitoneal fibrosis</span></span></span></p>"
      },
      {
        "id": 56768,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with enlargement of salivary glands, fibrosis of the pancreas, and increased serum levels of IgG4. Which condition from the following list is not typically associated with the spectrum of IgG4-related disease?</span></span></span></p>",
    "unique_key": "Q2160097",
    "question_audio": null,
    "question_video": null,
    "map_id": 31878,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Celiac disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease is <strong>not an lgG4-related disease.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgG4-related disease (IgG4-RD) </strong>is a newly recognized constellation of disorders characterized by <strong>tissue infiltrates dominated by IgG4 antibody-producing plasma cells and lymphocytes, particularly T cells, storiform fibrosis, obliterative phlebitis</strong>, and usually <strong>increased serum IgG4</strong>. IgG4-RD spectrum includes:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Celiac disease is an <strong>autoimmune </strong>condition triggered by <strong>ingestion of gluten </strong>in genetically<strong> susceptible </strong>individuals. It is <strong>not associated with IgG4-related disease</strong>, which is characterized by<strong> tissue infiltrates dominated by IgG4-positive plasma cells and lymphocytes, storiform fibrosis, and obliterative phlebitis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Mikulicz syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mikulicz syndrome involves <strong>enlargement and fibrosis of the salivary and lacrimal glands </strong>and is a recognized part of the<strong> IgG4-related disease spectrum</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Riedel thyroiditis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Riedel thyroiditis is a<strong> fibrosing inflammatory process </strong>involving the<strong> thyroid gland</strong>, often associated with <strong>IgG4-related disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Idiopathic retroperitoneal fibrosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Idiopathic retroperitoneal fibrosis is characterized by <strong>fibrous tissue </strong>in the <strong>retroperitoneum and can be associated with IgG4-related disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgG4-related disease </strong>is a <strong>fibro-inflammatory </strong>condition characterized by several features, including <strong>tissue infiltration with IgG4-positive plasma cells</strong>. It <strong>does not encompass celiac disease</strong>, which has a d<strong>ifferent pathophysiology related to gluten sensitivity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref Robbins 10<sup>th</sup>/232</span></span></strong></p>",
    "correct_choice_id": 56768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14160,
    "choices": [
      {
        "id": 56601,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute rejection</span></span></span></p>"
      },
      {
        "id": 56602,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperacute rejection</span></span></span></p>"
      },
      {
        "id": 56603,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic rejection</span></span></span></p>"
      },
      {
        "id": 56604,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graft versus host disease</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Runt disease is associated with:</span></span></span></p>",
    "unique_key": "Q2593698",
    "question_audio": null,
    "question_video": null,
    "map_id": 31856,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Graft versus host disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graft versus Host Disease (GVHD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> GVHD occurs in the context of bone marrow or stem cell transplants when immunocompetent donor T cells recognize the recipient&#39;s tissues as foreign and initiate an immune response against them. It can present acutely or chronically and can affect various organs, including the skin, liver, and gastrointestinal tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acute Rejection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a cell-mediated immune response that occurs days to months after transplantation. It involves direct cytotoxicity and inflammation, primarily affecting solid organ transplants, not typically associated with bone marrow transplants.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hyperacute Rejection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This type of rejection occurs within minutes to hours after transplantation due to pre-existing antibodies in the recipient against graft antigens, leading to rapid thrombosis and necrosis of the graft. It is usually associated with organ transplants.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Chronic Rejection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Chronic rejection is a long-term process where the graft is slowly lost over months to years due to a complex interplay of cellular and humoral immune responses. It often manifests as a gradual loss of function of the transplanted organ.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GVHD, exemplified by &quot;runt disease&quot; in the question, is a condition wherein immunocompetent cells from a donor mount an immune response against the host&#39;s tissues. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ p236)</span></strong></span></span></p>",
    "correct_choice_id": 56604,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14161,
    "choices": [
      {
        "id": 56605,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C3d </span></span></span></p>"
      },
      {
        "id": 56606,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C5a</span></span></span></p>"
      },
      {
        "id": 56607,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C3b </span></span></span></p>"
      },
      {
        "id": 56608,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C4d</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient who has undergone kidney transplantation and is now presenting with signs of renal dysfunction, which complement activation product is a known histological marker for the diagnosis of antibody-mediated rejection in transplant biopsies?</span></span></span></p>",
    "unique_key": "Q4208445",
    "question_audio": null,
    "question_video": null,
    "map_id": 31857,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) C4d </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C4d:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> C4d is a split product of the <strong>complement protein C4 </strong>and is considered a<strong> specific </strong>marker for the <strong>classic pathway of complement</strong> activation in the context of <strong>antibody-mediated rejection.</strong> Its presence in <strong>peritubular capillaries</strong> is associated with the <strong>rejection</strong> process.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: C3d:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> C3d is a breakdown product of the complement<strong> component C3 </strong>and can indicate <strong>complement activation</strong>, but it is <strong>not the most specific marker for antibody-mediated rejection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: C5a:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> C5a is an <strong>anaphylatoxin </strong>produced during complement activation that has potent inflammatory effects and can <strong>recruit neutrophils and macrophages</strong>. While it plays a role in<strong> inflammation</strong>, it is<strong> not </strong>typically used as a histological marker for <strong>antibody-mediated rejection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: C3b:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> C3b is another breakdown product of C3 and<strong> acts as an opsonin </strong>that promotes <strong>phagocytosis and further complement activation. </strong>It is not specifically used as a marker for antibody-mediated rejection in transplant patients.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C4d</strong> is the specific histological marker used to identify <strong>antibody-mediated rejection in organ transplants</strong>. Its detection is <strong>significant for the diagnosis and management of this type of rejection</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 238)</span></span></strong></p>",
    "correct_choice_id": 56608,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14165,
    "choices": [
      {
        "id": 56621,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preformed antibodies </span></span></span></p>"
      },
      {
        "id": 56622,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic T-lymphocyte mediated injury </span></span></span></p>"
      },
      {
        "id": 56623,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Circulating macrophage mediated injury </span></span></span></p>"
      },
      {
        "id": 56624,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelitis caused by donor antibodies </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperacute rejection is due to?</span></span></span></p>",
    "unique_key": "Q3826703",
    "question_audio": null,
    "question_video": null,
    "map_id": 31858,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Preformed antibodies </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lsquo;<strong>Hyperacute rejection </strong>occurs when <strong>preformed antidonor antibodies </strong>are present in the circulation of the recipient&rsquo;</span></em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preformed antibodies:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hyperacute rejection is mediated by preformed antibodies in the recipient that immediately react with the graft, leading to rapid thrombosis and ischemia of the transplanted organ.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Cytotoxic T-lymphocyte mediated injury:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While cytotoxic T-lymphocytes play a crucial role in cellular rejection, they are not typically involved in the immediate rejection seen in hyperacute reactions, which occur due to the presence of pre-existing antibodies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Circulating macrophage mediated injury:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Macrophages are involved in antibody-mediated responses and can contribute to cellular rejection; however, they are not the primary mediators of hyperacute rejection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Endothelitis caused by donor antibodies:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endothelitis is associated with acute and chronic rejection due to the recipient&#39;s immune response against the donor endothelium, not the other way around. Donor antibodies do not cause hyperacute rejection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of preformed antibodies against donor antigens in the recipient&#39;s blood is the primary cause of hyperacute rejection. This type of rejection can occur due to prior sensitization to HLA antigens through pregnancy, blood transfusions, or previous transplants</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 233-234) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 56621,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14177,
    "choices": [
      {
        "id": 56669,
        "text": "<p><span style=\"font-size:12pt;\">Skin</span></p>"
      },
      {
        "id": 56670,
        "text": "<p><span style=\"font-size:12.0pt;\">GIT</span></p>"
      },
      {
        "id": 56671,
        "text": "<p><span style=\"font-size:12pt;\">Liver</span></p>"
      },
      {
        "id": 56672,
        "text": "<p><span style=\"font-size:12pt;\">Lung</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old female patient, six weeks post-hematopoietic stem cell transplantation, presents with a widespread rash, severe diarrhea, and jaundice. She underwent transplantation for acute myelogenous leukemia and received cells from a matched unrelated donor. Which organ is least likely to be affected by graft-versus-host disease (GVHD) in this patient?</span></p>",
    "unique_key": "Q4094692",
    "question_audio": null,
    "question_video": null,
    "map_id": 31855,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Lung</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>GVHD </strong>affects <strong>skin (earliest organ), intestine and liver&nbsp;</strong> Lungs are <strong>not </strong>affected in GVHD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Lung:</strong> </span><span style=\"font-size:12.0pt;\">It is LEAST likely to be affected.&nbsp;L</span><span style=\"font-size:12pt;\">ung can be involved in <strong>chronic GVHD</strong>, manifesting as <strong>bronchiolitis obliterans, </strong>it is not commonly affected in acute GVHD, which typically involves the skin, GIT, and liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Skin:</strong> The skin is often the<strong> earliest and most commonly affected organ in GVHD</strong>, presenting with <strong>rash </strong>and potential progression to <strong>desquamation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: GIT (Gastrointestinal Tract):</strong> The GIT is a major target in<strong> GVHD</strong>, often manifesting as <strong>diarrhea, </strong>which can range from <strong>mild to severe, </strong>and may be associated with <strong>abdominal pain and bleeding.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Liver:</strong> Hepatic involvement in GVHD typically presents with jaundice and elevated liver enzymes, which can progress to severe liver dysfunction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In<strong> GVHD, the skin, GIT, and liver are commonly involved</strong>, while the<strong> lungs are less frequently </strong>affected, particularly in the <strong>acute phase of the disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 236)</strong></span></p>",
    "correct_choice_id": 56672,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14172,
    "choices": [
      {
        "id": 56649,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-cell removal </span></span></span></p>"
      },
      {
        "id": 56650,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prior immune suppression </span></span></span></p>"
      },
      {
        "id": 56651,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post procedure immune suppression </span></span></span></p>"
      },
      {
        "id": 56652,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which combination of strategies is employed to minimize the risk of graft-versus-host disease (GVHD) following bone marrow transplantation? </span></span></span></p>",
    "unique_key": "Q2945442",
    "question_audio": null,
    "question_video": null,
    "map_id": 31859,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the Above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> All the listed methods are <strong>integrated approaches </strong>to prevent <strong>GVHD. </strong>This includes matching <strong>donor and recipient HLA types </strong>as closely as possible, the <strong>use of immunosuppressive drugs</strong>, <strong>T-cell depletion of the graft, </strong>and <strong>post-transplant immunosuppression.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: T-cell Removal:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> T-cell depletion from the<strong> donor graft </strong>is a method used to reduce the<strong> incidence and severity of GVHD </strong>by removing the cells most responsible for the <strong>alloreactive response</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Prior Immune Suppression:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immunosuppressive therapy prior to<strong> transplantation </strong>can reduce the<strong> recipient&#39;s immune response </strong>to the donor graft and is used to condition the recipient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Post Procedure Immune Suppression:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Following the<strong> transplantation, immunosuppressive </strong>drugs such as <strong>methotrexate and cyclophosphamide </strong>are used to further<strong> prevent GVHD.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> prevention of GVHD in bone marrow transplantation </strong>involves a<strong> multimodal approach</strong>, including <strong>optimal donor matching, pre-transplant </strong>conditioning with <strong>immunosuppressive drugs, T-cell depletion of the donor marrow, and post-transplant immunosuppression</strong>. </span></span></p>",
    "correct_choice_id": 56652,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14217,
    "choices": [
      {
        "id": 56829,
        "text": "<p><span style=\"font-size:12pt;\">Congo red is the commonest stain used for diagnosis</span></p>"
      },
      {
        "id": 56830,
        "text": "<p><span style=\"font-size:12pt;\">Electron microscopy shows non branching fibrils</span></p>"
      },
      {
        "id": 56831,
        "text": "<p><span style=\"font-size:12pt;\">Spectroscopy shows beta pleated structure</span></p>"
      },
      {
        "id": 56832,
        "text": "<p><span style=\"font-size:12pt;\">Apple green birefringence with PAS staining</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 65-year-old male presents with numbness and tingling in his hands and feet. He also reports weakness and difficulty walking. Examination reveals enlarged tongue, carpal tunnel syndrome, and a waddling gait. Biopsy of the sural nerve shows deposits of amyloid protein. Which of the following is not correct about this condition?</span></p>",
    "unique_key": "Q2067525",
    "question_audio": null,
    "question_video": null,
    "map_id": 31874,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Apple green birefringence with PAS staining</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is the <strong>incorrect </strong>statement. <strong>PAS (Periodic Acid-Schiff) staining </strong>is used to detect <strong>polysaccharides, mucosubstances, and glycoproteins in tissues</strong>. <strong>Amyloid </strong>is<strong> not positive with PAS staining; </strong>instead, it is the <strong>Congo red </strong>staining that demonstrates <strong>apple green birefringence </strong>under <strong>polarized light</strong>. PAS staining usually shows <strong>amyloid as a magenta or pink color</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Congo red staining </strong>is indeed the most common method used for the <strong>diagnosis of amyloidosis</strong>. When viewed under <strong>polarized light, amyloid deposits </strong>stained with Congo red show a characteristic <strong>apple green birefringence.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Electron microscopy of amyloid fibrils </strong>typically shows <strong>non-branching, linear fibrils</strong>. This is <strong>due to the beta-pleated sheet configuration </strong>of the proteins that <strong>make up the fibrils</strong>, which is a <strong>hallmark of amyloid deposits</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>On spectroscopy</strong>, the<strong> beta-pleated sheet </strong>conformation of the <strong>amyloid fibrils </strong>results in a <strong>distinct pattern</strong>. This structure is <strong>stable and resistant to proteolysis</strong>, which is why amyloid deposits are typically <strong>insoluble </strong>and accumulate in various tissues.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Amyloid deposits do not exhibit apple green birefringence when stained with PAS; this characteristic is observed with Congo red staining under polarized light.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Apple green birefringence is seen with Congo red under polarised light</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Robbins 10<sup>th</sup>/259</strong></span></p>",
    "correct_choice_id": 56832,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14163,
    "choices": [
      {
        "id": 56613,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of amyloid proteins in the extracellular space </span></span></span></p>"
      },
      {
        "id": 56614,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of amyloid proteins in the intracellular space </span></span></span></p>"
      },
      {
        "id": 56615,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of amyloid proteins in the cytoplasmic space </span></span></span></p>"
      },
      {
        "id": 56616,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of amyloid proteins in the mitochondrial space</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with progressive fatigue, kidney dysfunction, and an echocardiogram suggesting restrictive cardiomyopathy, a biopsy is performed, and the pathologist observes eosinophilic, fibrillary material in the tissue that stains with Congo red. This finding is most consistent with which pattern of protein accumulation in amyloidosis?</span></span></span></p>",
    "unique_key": "Q7502327",
    "question_audio": null,
    "question_video": null,
    "map_id": 31875,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Accumulation of amyloid proteins in the extracellular space</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amyloidosis is </strong>a disorder characterized by the abnormal<strong> accumulation of insoluble, fibrous protein aggregates </strong>known as <strong>amyloid fibrils</strong>. These fibrils deposit in<strong> various tissues and organs</strong>, leading to <strong>organ dysfunction. </strong>The accumulation of <strong>amyloid proteins </strong>occurs primarily in the <strong>extracellular space, causing disruption of tissue architecture and function.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><u><strong>Explanation :</strong></u></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>intracellular accumulation of amyloid proteins</strong>, is <strong>not a key feature of amyloidosis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C and D:&nbsp;</strong>accumulation of <strong>amyloid proteins in the cytoplasmic and mitochondrial space</strong>, respectively, are also not key features of amyloidosis.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key feature of <strong>amyloidosis is the extracellular accumulation of amyloid proteins</strong>, which can lead to a range of clinical manifestations depending on the organs affected. </span></span></span></p>",
    "correct_choice_id": 56613,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14215,
    "choices": [
      {
        "id": 56821,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood culture </span></span></span></p>"
      },
      {
        "id": 56822,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine culture </span></span></span></p>"
      },
      {
        "id": 56823,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone marrow biopsy </span></span></span></p>"
      },
      {
        "id": 56824,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biopsy of affected tissue</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a history of chronic inflammatory disease presents with fatigue, weight loss, and edema. Physical examination reveals macroglossia and periorbital purpura. Laboratory studies show renal insufficiency and proteinuria. To confirm the suspected diagnosis of amyloidosis, which of the following diagnostic tests should be performed?</span></span></span></p>",
    "unique_key": "Q2013403",
    "question_audio": null,
    "question_video": null,
    "map_id": 31876,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Biopsy of affected tissue</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A definitive diagnosis of <strong>amyloidosis </strong>requires a <strong>biopsy of affected tissue, such as the skin, kidney, liver, or gastrointestinal tract. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>biopsy specimen </strong>is examined under a microscope to identify the presence of <strong>amyloid fibrils</strong>. Additional tests, such as<strong> immunohistochemistry, mass spectrometry, or electron microscopy, </strong>may be used to determine the <strong>specific type of amyloid protein </strong>involved.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Biopsy </strong>of affected tissue is the<strong> gold standard for confirming the diagnosis of amyloidosis</strong>. It involves taking a sample from affected organs like the<strong> kidney, liver, or gastrointestinal tract </strong>and identifying <strong>amyloid fibrils under a microscope </strong>with additional confirmatory tests such as<strong> immunohistochemistry or electron microscopy.</strong></span></span></p>",
    "correct_choice_id": 56824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 14212,
    "choices": [
      {
        "id": 56809,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bruton X-linked agammaglobulinemia</span></span></span></p>"
      },
      {
        "id": 56810,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DiGeorge syndrome</span></span></span></p>"
      },
      {
        "id": 56811,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isolated IgA deficiency</span></span></span></p>"
      },
      {
        "id": 56812,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe combined immunodeficiency</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 9-month-old girl with a history of recurrent pulmonary infections is found to have a congenital deficiency of adenosine deaminase, which is associated with a virtual absence of lymphocytes in her peripheral lymphoid organs. What is the appropriate diagnosis?</span></span></span></p>",
    "unique_key": "Q6234971",
    "question_audio": null,
    "question_video": null,
    "map_id": 31781,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Severe combined immunodeficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Severe combined immunodeficiency (SCID) </strong>is a group of disorders of <strong>T and B lymphocytes </strong>that are characterized by <strong>recurrent viral, bacterial, fungal, and protozoal infections. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Many <strong>infants with SCID </strong>have severely reduced volumes of <strong>lymphoid tissue and an immature thymus </strong>that<strong> lacks lymphocytes</strong>. In some patients, <strong>lymphocytes fail </strong>to develop beyond <strong>pre-B cells and pre-T cells. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some children with SCID have<strong> adenosine deaminase deficiency </strong>which causes the <strong>accumulation of intermediate products </strong>that are<strong> toxic to lymphocytes. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Bruton X-linked agammaglobulinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a disorder characterized by the absence of<strong> B cells and low levels of all immunoglobulins, </strong>but it does not typically involve T cells or adenosine deaminase deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: DiGeorge syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition is due to <strong>thymic hypoplasia or aplasia, </strong>leading to<strong> T cell deficiency</strong>. While it may present with<strong> recurrent infections</strong>, it is not associated with adenosine deaminase deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Isolated IgA deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the most common<strong> primary immunodeficiency </strong>and usually presents with <strong>recurrent mucosal infections</strong>. It is characterized by <strong>low or absent IgA </strong>levels but does not involve a<strong> global lack of lymphocytes or adenosine deaminase deficiency</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>SCID </strong>is a group of disorders involving both<strong> B and T cell deficiencies</strong>. <strong>Adenosine deaminase deficiency </strong>is a specific form of<strong> SCID </strong>that leads to the accumulation of<strong> metabolites toxic to lymphocytes, resulting in their absence.</strong></span></span></span></p>",
    "correct_choice_id": 56812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 14152,
    "choices": [
      {
        "id": 56569,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B cell tyrosine kinase activity detection</span></span></span></p>"
      },
      {
        "id": 56570,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WASP gene mutation</span></span></span></p>"
      },
      {
        "id": 56571,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine deaminase activity </span></span></span></p>"
      },
      {
        "id": 56572,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ANA titre </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical scenario where a male child presents with recurrent infections, eczema, and thrombocytopenia, which of the following genetic evaluations is most appropriate to confirm the suspected diagnosis?</span></span></span></p>",
    "unique_key": "Q1160016",
    "question_audio": null,
    "question_video": null,
    "map_id": 31782,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) WASP gene mutation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WASP gene mutation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> WASP gene mutations are associated with <strong>Wiskott-Aldrich syndrome, </strong>which is characterized by the <strong>triad of eczema, thrombocytopenia (low platelet count), and immunodeficiency</strong>, which can include a<strong> high risk of infections.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: B cell tyrosine kinase activity detection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The detection of<strong> B cell tyrosine kinase activity </strong>is relevant for <strong>X-linked agammaglobulinemia (XLA)</strong>, which is characterized by the <strong>absence of mature B cells and low levels of immunoglobulins. </strong>This condition <strong>does not </strong>typically present with <strong>eczema or thrombocytopenia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Adenosine deaminase activity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Reduced or absent adenosine deaminase activity </strong>is characteristic of <strong>severe combined immunodeficiency (SCID), </strong>which presents with severe <strong>recurrent infections</strong>. However, SCID <strong>does not </strong>typically involve <strong>eczema or thrombocytopenia </strong>as presenting features.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: ANA titre:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> ANA titres are typically measured when <strong>autoimmune conditions, such as systemic lupus erythematosus (SLE), </strong>are suspected. These conditions can present with<strong> rash and are associated with immune dysregulation</strong>, but they <strong>do not typically cause thrombocytopenia as a primary manifestation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a male child with recurrent infections, eczema, and thrombocytopenia, the most appropriate genetic evaluation is testing for WASP gene mutations to confirm a diagnosis of Wiskott-Aldrich syndrome. </span></span></p>",
    "correct_choice_id": 56570,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14175,
    "choices": [
      {
        "id": 56661,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IgG </span></span></p>"
      },
      {
        "id": 56662,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
      },
      {
        "id": 56663,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;IgA </span></span></p>"
      },
      {
        "id": 56664,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with cerebellar ataxia, telangiectasias, and recurrent respiratory infections. Laboratory investigations show immunodeficiency. Which immunoglobulin is most commonly deficient in this patient, who is likely to have Ataxia-Telangiectasia?</span></span></span></p>",
    "unique_key": "Q7402101",
    "question_audio": null,
    "question_video": null,
    "map_id": 31789,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) IgA </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with<strong> ataxia telangiectasia (AT) </strong>present in the <strong>first decade of life</strong> with <strong>progressive telangiectatic lesions </strong>associated with deficits in<strong> cerebellar function and nystagmus</strong>. There is a high incidence of <strong>recurrent pulmonary infections </strong>(<strong>bronchiectasis</strong>) and <strong>neoplasms of the lymphatic and reticuloendothelial system. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is caused due to <strong>defect in DNA repair genes</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymic hypoplasia with <strong>cellular and humoral (IgA and IgG2) immunodeficiencies</strong>, <strong>premature aging </strong>and endocrine disorders such as <strong>insulin resistance or type-I DM</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most striking neuropathologic changes include <strong>loss of Purkinje, granule and basket cells </strong>in the cerebellar cortex as well as of neurons in the deep cerebellar nuclei. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>poorly developed or absent thymus gland </strong>is the most consistent defect of the lymphoid system. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most <strong>consistent immunoglobulin </strong>deficiency observed in<strong> Ataxia-Telangiectasia is IgA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 242-243)</span></span></em></strong></p>",
    "correct_choice_id": 56663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14176,
    "choices": [
      {
        "id": 56665,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymph nodes </span></span></span></p>"
      },
      {
        "id": 56666,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opportunistic infections </span></span></span></p>"
      },
      {
        "id": 56667,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CNS lesions </span></span></span></p>"
      },
      {
        "id": 56668,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaposi&rsquo;s sarcoma (blood vessels) </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following lesions/conditions shows most specific anatomic changes in HIV infection?</span></span></p>",
    "unique_key": "Q1037877",
    "question_audio": null,
    "question_video": null,
    "map_id": 31776,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) CNS lesions </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CNS Lesions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Central nervous system (CNS) lesions in<strong> HIV-infected patients </strong>can show specific pathologic changes, such as those seen in <strong>HIV encephalitis, progressive multifocal leukoencephalopathy, or primary CNS lymphoma</strong>, which are more diagnostic of HIV&#39;s effects on the brain compared to other conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lymph Nodes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lymph nodes in HIV infection often show<strong> non-specific changes such as lymphadenopathy, </strong>which are<strong> not unique to HIV.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Opportunistic Infections:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Opportunistic infections associated with <strong>HIV </strong>can present with a variety of<strong> histological patterns</strong>, depending on the<strong> organism involved</strong>, but these changes are <strong>not specific to HIV itself.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Kaposi&rsquo;s Sarcoma (Blood Vessels):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Kaposi&rsquo;s sarcoma is associated with <strong>HIV infection </strong>but is caused by<strong> human herpesvirus 8 (HHV-8) infection</strong>. Its presence in the <strong>skin or organs isn&#39;t specific for HIV, </strong>as it can occur in other <strong>immunosuppressed states</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> CNS lesions </strong>in patients with <strong>HIV </strong>are among the<strong> few pathological findings </strong>that can be<strong> specific and diagnostic</strong>, reflecting the unique <strong>neuropathology associated with HIV infection </strong>and its complications. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote from Robbins&hellip;. <em>&ldquo;The anatomic changes in the tissues <strong>(except of lesions in the brain</strong>) are neither specific nor diagnostic&rdquo;.</em></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 254-255)</span></em></strong></span></span></p>",
    "correct_choice_id": 56667,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 14178,
    "choices": [
      {
        "id": 56673,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medulloblastoma </span></span></span></p>"
      },
      {
        "id": 56674,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astrocytoma </span></span></span></p>"
      },
      {
        "id": 56675,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary CNS Iymphoma </span></span></span></p>"
      },
      {
        "id": 56676,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ependymoma </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an HIV-positive patient presenting with neurological symptoms, imaging studies reveal a mass lesion in the brain. Which type of CNS neoplasm is most commonly associated with this clinical scenario?</span></span></span></p>",
    "unique_key": "Q6496993",
    "question_audio": null,
    "question_video": null,
    "map_id": 31778,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Primary CNS Iymphoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary CNS Lymphoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Primary CNS lymphoma is frequently associated with<strong> immunosuppression </strong>seen in <strong>HIV-infected individuals</strong>, particularly when the<strong> CD4 count is low, </strong>and often has a correlation with<strong> EBV infection</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Medulloblastoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Medulloblastoma is a type of <strong>malignant primary brain tumor </strong>most commonly <strong>found in children </strong>and is <strong>not </strong>particularly associated with<strong> HIV or immunosuppression</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Astrocytoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Astrocytomas are a broad<strong> group of glial tumors </strong>and can occur in individuals<strong> with or without HIV</strong>. They are not the most common CNS neoplasm in the setting of HIV.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Ependymoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ependymomas are tumors derived from<strong> ependymal cells </strong>of the<strong> ventricular system </strong>and are not specifically associated with HIV or immunosuppression.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary CNS lymphoma </strong>is the<strong> most common CNS neoplasm </strong>in patients <strong>with HIV, </strong>particularly in those with <strong>severe immunosuppression. </strong>It is typically of<strong> B-cell origin </strong>and often associated with<strong> EBV infection. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 9/e p254-255)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><em> </em></span></strong></span></span></p>",
    "correct_choice_id": 56675,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 14179,
    "choices": [
      {
        "id": 56677,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whole blood </span></span></span></p>"
      },
      {
        "id": 56678,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelets </span></span></span></p>"
      },
      {
        "id": 56679,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma derived Hepatitis B vaccine </span></span></span></p>"
      },
      {
        "id": 56680,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocytes </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient concerned about the risk of HIV transmission through medical products is reassured that certain blood products and derivatives are safe and do not pose a risk of transmitting HIV due to the methods of processing involved. Which of the following is NOT associated with the transmission of HIV?</span></span></span></p>",
    "unique_key": "Q2205712",
    "question_audio": null,
    "question_video": null,
    "map_id": 31779,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Plasma derived Hepatitis B vaccine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per Harrison, <strong>Transfusions of whole blood, packed red blood cells, platelets, leukocytes, and plasma </strong>are all capable of <strong>transmitting HIV infection</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In contrast, <strong>hyperimmune gamma globulin, hepatitis B immune globulin, plasma-derived hepatitis B vaccine, and Rho immune globulin </strong>have <strong>not been </strong>associated with transmission of<strong> HIV infection. </strong>The procedures involved in processing these products either <strong>inactivate or remove the virus.</strong>&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma Derived Hepatitis B Vaccine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Plasma-derived Hepatitis B vaccines are processed to <strong>remove any viral particles</strong>, including <strong>HIV, </strong>effectively preventing the<strong> transmission of HIV</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Whole Blood:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Transfusions of whole blood have a <strong>risk of HIV transmission if the blood is contaminated</strong>, as HIV can be present in <strong>sufficient quantities to establish an infection in the recipient.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Platelets:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Platelet transfusions carry a <strong>risk of HIV transmission if the donor blood is infected, </strong>as<strong> platelets </strong>are derived from <strong>whole blood which may contain the virus</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Leukocytes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Transfusions involving <strong>leukocytes (white blood cells) can transmit HIV, </strong>as these cells can <strong>harbor the virus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Plasma-derived Hepatitis B vaccines </strong>are not associated with the<strong> transmission of HIV </strong>because of the rigorous methods used to <strong>inactivate or remove viral contaminants </strong>during the <strong>manufacturing process</strong></span></span></p>",
    "correct_choice_id": 56679,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 14180,
    "choices": [
      {
        "id": 56681,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA &ndash;PCR </span></span></span></p>"
      },
      {
        "id": 56682,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Viral culture </span></span></span></p>"
      },
      {
        "id": 56683,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV ELISA </span></span></span></p>"
      },
      {
        "id": 56684,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">P 24 antigen assay</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In evaluating a 2-month-old infant for HIV infection, which diagnostic method is NOT appropriate due to the potential for false-positive results from passive transfer of maternal antibodies?</span></span></span></p>",
    "unique_key": "Q6022687",
    "question_audio": null,
    "question_video": null,
    "map_id": 31780,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"DE\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) HIV ELISA&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV ELISA is required for detection of<strong> antibodies against the virus</strong>. The antibodies may be present in the <strong>infant </strong>because of <strong>maternal infection </strong>also because <strong>IgG antibodies can cross the placental barrier. </strong>So, the presence of <strong>anti-HIV antibodies is not reliable for diagnosis of HIV in a 2-month-old child. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV ELISA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HIV ELISA detects<strong> HIV antibodies</strong>, which may be transferred from<strong> the mother to the infant,</strong> persisting for <strong>several months after birth</strong>. Therefore, it is <strong>not a reliable test for diagnosing HIV in an infant two months of age </strong>due to the potential for<strong> maternal antibody interference</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: DNA-PCR:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> DNA-PCR is a sensitive method for detecting the presence of <strong>HIV DNA within a child&#39;s cells </strong>and can be used from <strong>birth to accurately diagnose congenital HIV infection</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Viral Culture:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Viral culture using <strong>peripheral blood mononuclear cells (PBMC) </strong>can be used to grow the <strong>virus from the infant&#39;s blood cells</strong>, providing direct evidence of <strong>HIV infection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: P24 Antigen Assay:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The p24 antigen assay detects<strong> viral core protein p24</strong>, which can be used to diagnose<strong> HIV infection in infants</strong>, as it is <strong>not affected by the presence of maternal antibodies</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In infants, direct detection methods for<strong> HIV such as DNA-PCR and p24 antigen assay</strong> are preferred over antibody detection methods like<strong> HIV ELISA</strong>, which can yield<strong> false-positive </strong>results due to the<strong> presence of maternal antibodies. </strong></span></span></p>",
    "correct_choice_id": 56683,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 14206,
    "choices": [
      {
        "id": 56785,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B lymphocytes</span></span></span></p>"
      },
      {
        "id": 56786,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Helper T lymphocytes</span></span></span></p>"
      },
      {
        "id": 56787,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Killer T lymphocytes</span></span></span></p>"
      },
      {
        "id": 56788,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monocytes/macrophages</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young truck driver with AIDS complains of difficulty swallowing. Examination of his oral cavity demonstrates whitish membranes covering much of his tongue and palate. He has similar lesions in his esophagus also. These pathologic findings are fundamentally caused by loss of which of the following immune cells in this patient?</span></span></span></p>",
    "unique_key": "Q6207871",
    "question_audio": null,
    "question_video": null,
    "map_id": 31788,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Helper T lymphocytes. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>HIV infection, infection of CD4+ (helper) T lymphocytes, </strong>which leads to the <strong>depletion of this cell population </strong>and impaired <strong>immune function</strong>. As a result, patients with <strong>AIDS usually die of opportunistic infections.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Helper T lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> HIV preferentially infects CD4+ helper T lymphocytes, </strong>leading to their <strong>depletion</strong>. The <strong>loss of helper T cells impairs cellular and humoral immunity</strong>, predisposing to <strong>opportunistic infections</strong>, such as<strong> oral candidiasis</strong>, indicated by the <strong>whitish membranes in the oral cavity and esophagus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: B lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B lymphocytes are responsible for <strong>humoral immunity and produce antibodies</strong>. While B cell function can be affected <strong>secondary to T cell impairment in HIV, </strong>the primary defect in AIDS is not the direct loss of B cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Killer T lymphocytes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CD8+ killer T lymphocytes, or <strong>cytotoxic T cells, are essential for killing virus-infected cells. </strong>While these cells can be affected in<strong> HIV/AIDS, the primary immunologic defect </strong>causing the susceptibility to opportunistic infections in AIDS is the <strong>loss of helper T cells, not cytotoxic T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Monocytes/macrophages:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Monocytes/macrophages are involved in <strong>phagocytosis and antigen presentation</strong>. They can be infected by <strong>HIV </strong>and play a role in the disease pathogenesis, but the fundamental defect causing the <strong>increased susceptibility to opportunistic infections in AIDS is the loss of CD4+ helper T cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> depletion of CD4+ helper T lymphocytes </strong>is the<strong> hallmark of HIV infection leading to AIDS</strong>. The consequent <strong>immunosuppression </strong>manifests as<strong> susceptibility to opportunistic infections</strong>, including <strong>oral and esophageal candidiasis. </strong></span></span></span></span></span></p>",
    "correct_choice_id": 56786,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14098,
    "choices": [
      {
        "id": 56353,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective respiratory burst</span></span></span></p>"
      },
      {
        "id": 56354,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective phagolysosome fusion</span></span></span></p>"
      },
      {
        "id": 56355,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective primary neutrophil granules</span></span></span></p>"
      },
      {
        "id": 56356,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in RAG gene</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 1 year old boy had complaints of recurrent fever. He had been treated for severe pneumonia 3 weeks back. Clinical examination revealed mild pallor, oral thrush, micrognathia, low-set right ear. Skin examination was remarkable with patchy hypopigmentation around face, trunk, back, abdomen, perianal region, hands and feet along with hypopigmented silver gray hair. Peripheral smear showed abnormal inclusions as shown in the given image. Identify the defect associated with this condition? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/picture2_9FQIxoB.jpg\" style=\"height:255px; width:300px\" /></p>",
    "unique_key": "Q5755755",
    "question_audio": null,
    "question_video": null,
    "map_id": 31786,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Defective phagolysosome fusion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis<strong> Chediak-Higashi syndrome- defect in phagolysosome fusion</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seen in<strong> Chronic granulomatous disease.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;MPO deficiency - This condition has minimal<strong> susceptibility to infection</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with <strong>X-linked SCID (Severe combined immunodeficiency disease)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chediak-Higashi syndrome </strong>is diagnosed by the presence of<strong> giant granules in leukocytes </strong>and is caused by a <strong>defect in the fusion of phagosomes with lysosomes</strong>, leading to <strong>impaired microbial killing</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran Pathologic Basis of disease 10th ed- Pg: 82,83</span></strong></span></span></p>",
    "correct_choice_id": 56354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 14125,
    "choices": [
      {
        "id": 56461,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in phagocytic cell migration </span></span></span></p>"
      },
      {
        "id": 56462,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in phagocytic cell activation </span></span></span></p>"
      },
      {
        "id": 56463,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in phagocytic cell killing </span></span></span></p>"
      },
      {
        "id": 56464,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in phagocytic cell proliferation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents with recurrent skin abscesses and infections. His medical history is significant for chronic granulomatous disease (CGD). What is the underlying pathophysiology of CGD?</span></span></p>",
    "unique_key": "Q9378922",
    "question_audio": null,
    "question_video": null,
    "map_id": 31784,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Defects in phagocytic cell killing</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CGD </strong>is an <strong>inherited disorder of the immune system </strong>that affects the<strong> function of phagocytic cells, such as neutrophils and macrophages</strong>. The underlying defect in CGD is a<strong> deficiency </strong>in one of the components of the<strong> nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex</strong>, which is responsible for<strong> generating reactive oxygen species (ROS) </strong>that are necessary for the killing of ingested microorganisms. As a result, individuals with CGD are more susceptible to bacterial and fungal infections, as well as chronic granulomatous inflammation.</span></span></span></p>",
    "correct_choice_id": 56463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15307,
    "choices": [
      {
        "id": 61188,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paroxysmal nocturnal haemoglobinuria </span></span></span></p>"
      },
      {
        "id": 61189,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anaemia </span></span></span></p>"
      },
      {
        "id": 61190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paroxysmal cold haemoglobinuria </span></span></span></p>"
      },
      {
        "id": 61191,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplastic syndrome </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the least likely to be a pre-leukaemic condition? <em>&nbsp;</em></span></span></span></p>",
    "unique_key": "Q8709888",
    "question_audio": null,
    "question_video": null,
    "map_id": 31783,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Paroxysmal cold haemoglobinuria </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PCH (paroxysmal cold hemoglobinu&shy;ria) </strong>is an <strong>autoimmune haemolytic anemia </strong>due to <strong>IgG autoanti&shy;bodies </strong>which bind to<strong> P blood group antigen </strong>and cause<strong> intravascu&shy;lar hemolysis and hemoglobinuria</strong>. Most cases are seen in <strong>children </strong>and have <strong>recovery within a month</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: &ldquo;PNH:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> about <strong>5% to 10% </strong>of patients eventually develop <strong>acute myeloid leukemia or a my&shy;elodysplastic syndrome</strong>, possibly because<strong> hematopoietic stem cells </strong>have suffered some type of<strong> genetic damage</strong>&rsquo;. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>results from a fundamental <strong>stem cell defect </strong>supported by the presence of<strong> karyotypic aberrations </strong>in many cases; the occasional trans&shy;formation of <strong>aplasia into myeloid neoplasms</strong>, typically <strong>myelodysplasia or acute myeloid leukemia; </strong>and the asso&shy;ciation with abnormally <strong>short telomeres</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The term <strong>&ldquo;myelodysplastic syndrome&rdquo; </strong>(MDS) refers to a group of <strong>clonal stem cell disorders </strong>characterized by<strong> maturation defects </strong>that are associated with<strong> ineffective hematopoiesis </strong>and a <strong>high risk of transformation to AML</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Paroxysmal Cold Hemoglobinuria (PCH) </strong>is primarily an <strong>autoimmune hemolytic anemia </strong>and <strong>not commonly </strong>associated with <strong>transformation to leukemia</strong>, which makes it the<strong> least likely condition to be pre-leukemic</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 545) </span></span></em></strong><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>",
    "correct_choice_id": 61190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 15357,
    "choices": [
      {
        "id": 61388,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 1a </span></span></p>"
      },
      {
        "id": 61389,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 1b </span></span></p>"
      },
      {
        "id": 61390,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 1c </span></span></p>"
      },
      {
        "id": 61391,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 1d</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The CD marker of histiocytosis is:</span></span></span></p>",
    "unique_key": "Q1332253",
    "question_audio": null,
    "question_video": null,
    "map_id": 31787,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp; CD 1a </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture6_YFhykpf.jpg\" style=\"height:275px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In Langerhans cell histiocytosis, </strong>tumor cells typically express the<strong> surface marker CD1a </strong>and contain <strong>intracytoplasmic Birbeck granules</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 620)</span></em></strong></span></span></p>",
    "correct_choice_id": 61388,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15520,
    "choices": [
      {
        "id": 62040,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurons</span></span></span></p>"
      },
      {
        "id": 62041,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astrocytes</span></span></span></p>"
      },
      {
        "id": 62042,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligodendroglial cells </span></span></span></p>"
      },
      {
        "id": 62043,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microglial cells</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neuropathologist is examining the brain from a patient with HIV, and, in the cerebral parenchyma, he identifies multinucleated cells. The virus is inducing a change in what type of cell to produce these giant cells? </span></span></p>",
    "unique_key": "Q7145022",
    "question_audio": null,
    "question_video": null,
    "map_id": 31777,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Microglial cells</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of multinucleated giant cells </strong>in the <strong>cerebral parenchyma </strong>of a patient with <strong>HIV </strong>is indicative of <strong>HIV encephalitis</strong>. In <strong>HIV infection</strong>, the <strong>virus primarily infects and replicates in CD4+ T cells </strong>and <strong>macrophages/microglial cells</strong>. The <strong>multinucleated giant cells</strong>, also known as <strong>&quot;syncytia,&quot; </strong>are formed by the <strong>fusion of infected microglial cells</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neurons</strong> are <strong>not </strong>typically the <strong>target cells for HIV replication</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Astrocytes</strong> are <strong>not </strong>the <strong>primary target cells for HIV replication</strong>; microglial cells play a more significant role.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligodendroglial cells</strong> are <strong>not </strong>the <strong>primary target cells for HIV</strong>; microglial cells are more commonly infected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>HIV encephalitis</strong>, specifically <strong>microglial cells </strong>contribute in the <strong>formation of multinucleated giant cells </strong>within the <strong>cerebral parenchyma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 1267</span></strong></span></span></p>",
    "correct_choice_id": 62043,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14205,
    "choices": [
      {
        "id": 56781,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid-stimulating hormone (TSH) receptor </span></span></span></p>"
      },
      {
        "id": 56782,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel</span></span></span></p>"
      },
      {
        "id": 56783,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine receptor </span></span></span></p>"
      },
      {
        "id": 56784,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid factor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged lady 30-year-old woman complains of diplopia and drooping eyelids. She undergoes investigation which reveals a mediastinal mass. The symptoms of muscle weakness in this patient are caused by antibodies directed against which of the following cellular components?</span></span></span></p>",
    "unique_key": "Q5060534",
    "question_audio": null,
    "question_video": null,
    "map_id": 31885,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acetylcholine receptor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Myasthenia gravis </strong>is a <strong>type II hypersensitivity disorder </strong>caused by<strong> antibodies </strong>that <strong>bind to the acetylcholine receptor.</strong> These <strong>antibodies interfere</strong> with the <strong>transmission of neural impulses </strong>at the <strong>neuromuscular junctio</strong>n, causing <strong>muscle weakness and easy fatigability. External ocular and eyelid muscles </strong>are most often affected, but the disease is <strong>often progressive and may cause death by respiratory muscle paralysis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies </strong>directed against the <strong>acetylcholine receptor </strong>at the <strong>neuromuscular junction </strong>are characteristic of <strong>myasthenia gravis</strong>. This condition often presents with o<strong>cular symptoms like diplopia and ptosis </strong>and may be associated with a <strong>thymoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Thyroid-stimulating hormone (TSH) receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies </strong>against the<strong> TSH receptor </strong>are characteristic of <strong>Graves&#39; disease</strong>, an autoimmune disorder that leads to<strong> hyperthyroidism</strong>, not typically associated with muscle weakness.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Calcium channel:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Antibodies to calcium channels </strong>is associated with <strong>Lambert-Eaton myasthenic syndrome, </strong>which can cause<strong> muscle weakness; </strong>however, the presence of a <strong>mediastinal mass is more suggestive of thymoma </strong>associated with <strong>myasthenia gravis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Rheumatoid factor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rheumatoid factor is an <strong>autoantibody </strong>observed in <strong>rheumatoid arthritis, </strong>which primarily affects joints and is not typically involved in th<strong>e neuromuscular transmission </strong>pathology seen in <strong>myasthenia gravis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of a<strong> mediastinal mass </strong>and symptoms such as <strong>diplopia and ptosis in a young adult </strong>are highly suggestive of <strong>myasthenia gravis</strong>, which is caused by<strong> autoantibodies against the acetylcholine receptor, </strong>leading to<strong> muscle weakness. </strong></span></span></p>",
    "correct_choice_id": 56783,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 15522,
    "choices": [
      {
        "id": 62048,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diminished calcium in the sarcoplasmic reticulum</span></span></span></p>"
      },
      {
        "id": 62049,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against the sarcoplasmic reticulum</span></span></span></p>"
      },
      {
        "id": 62050,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accelerated uptake of the neurotransmitter at the nerve-muscle junction</span></span></span></p>"
      },
      {
        "id": 62051,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 67-year-old male with a history of smoking and a recent diagnosis of small-cell lung carcinoma presents with a chief complaint of increasing weakness, particularly in the proximal muscles of his limbs. He reports that the weakness improves with repeated use of the muscles. Electromyography reveals a decremental response in muscle action potential amplitude with low-frequency stimulation, which improves with high-frequency stimulation. </span></span><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of muscle weakness in Lambert-Eaton syndrome is which of the following? </span></span></p>",
    "unique_key": "Q2087031",
    "question_audio": null,
    "question_video": null,
    "map_id": 31884,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans D) Antibody against presynaptic channels at the nerve-muscle junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario, <strong>weakness in the proximal muscle groups</strong>, associated with a <strong>pulmonary neoplasm </strong>with metastases, is consistent with <strong>Lambert-Eaton syndrome</strong> associated with <strong>small-cell carcinoma</strong>. In Lambert-Eaton syndrome, the tumor causes the production of an <strong><em>antibody directed against the presynaptic calcium channels</em></strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody against presynaptic channels at the nerve-muscle junction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the correct mechanism. In <strong>Lambert-Eaton syndrome</strong>, <strong>antibodies </strong>target the <strong>voltage-gated calcium channels </strong>on the <strong>presynaptic terminal</strong>, <strong>impairing </strong>the <strong>release of acetylcholine</strong>, and thus leading to <strong>muscle weakness</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diminished calcium in the sarcoplasmic reticulum </strong>would <strong>affect muscle contraction </strong>but is <strong>not the mechanism of muscle weakness </strong>seen in Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>antibody against the sarcoplasmic reticulum</strong> is <strong>not associated with Lambert-Eaton syndrome</strong>. Antibodies in LEMS are directed against voltage-gated calcium channels on the presynaptic nerve terminal, not against the sarcoplasmic reticulum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accelerated uptake of neurotransmitter at the nerve-muscle junction</strong> would likely lead to a <strong>decrease in available neurotransmitter </strong>for <strong>muscle contraction</strong>, but this is not the pathophysiology of Lambert-Eaton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle weakness </strong>in <strong>Lambert-Eaton syndrome </strong>is due to <strong>antibodies against presynaptic voltage-gated calcium channels </strong>at the <strong>nerve-muscle junction</strong>, impairing acetylcholine release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1226</span></strong></span></span></p>",
    "correct_choice_id": 62051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "InvestigationBased"
    ]
  }
];
        let quizName = 'Immunity';
        const quizFilename = 'immunity-174a1e0f.html';
        let hierarchy = ["Cerebellum", "qBank", "Pathology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>